HealthTopic,Population,Indicator,Unit,Time,RegionCode,RegionName,NumValue,TxtValue
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,14,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,6,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,1,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,AT,Austria,6,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,BE,Belgium,7,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,BG,Bulgaria,158,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,CY,Cyprus,113,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,CZ,Czechia,32,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,DE,Germany,21,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,DK,Denmark,2,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,EE,Estonia,3,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,EL,Greece,1373,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,ES,Spain,25,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,FI,Finland,1,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,HR,Croatia,242,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,HU,Hungary,169,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,IE,Ireland,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,IT,Italy,2252,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,LT,Lithuania,99,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,LU,Luxembourg,1,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,LV,Latvia,39,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,MT,Malta,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,NL,Netherlands,10,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,NO,Norway,1,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,PL,Poland,295,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,PT,Portugal,43,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,RO,Romania,235,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,SE,Sweden,2,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,SI,Slovenia,13,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,R - resistant isolates,N,2023,SK,Slovakia,36,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,AT,Austria,8.45070422,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,4.69798657,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,86.33879781,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,83.7037037,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,35.16483516,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,DE,Germany,2.77410832,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,2.24719101,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,-,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,EL,Greece,88.12580231,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,ES,Spain,32.89473684,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,FI,Finland,3.03030303,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,92.36641221,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,39.6713615,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,-,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,IT,Italy,73.57072852,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,82.5,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,-,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,50.64935064,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,MT,Malta,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,4.71698113,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,NO,Norway,2.5,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,PL,Poland,68.12933025,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,28.28947368,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,RO,Romania,82.45614035,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,1.30718954,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,25,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,47.36842105,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,AT,Austria,65,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,BE,Belgium,128,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,BG,Bulgaria,25,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,CY,Cyprus,22,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,CZ,Czechia,59,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,DE,Germany,730,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,DK,Denmark,87,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,EE,Estonia,7,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,EL,Greece,185,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,ES,Spain,51,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,FI,Finland,32,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,HR,Croatia,20,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,HU,Hungary,257,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,IE,Ireland,58,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,IS,Iceland,1,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,IT,Italy,808,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,LT,Lithuania,21,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,LU,Luxembourg,6,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,LV,Latvia,38,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,MT,Malta,21,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,NL,Netherlands,202,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,NO,Norway,39,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,PL,Poland,138,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,PT,Portugal,109,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,RO,Romania,50,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,SE,Sweden,151,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,SI,Slovenia,39,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,S - susceptible isolates,N,2023,SK,Slovakia,40,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,AT,Austria,71,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,BE,Belgium,149,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,BG,Bulgaria,183,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,CY,Cyprus,135,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,CZ,Czechia,91,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,DE,Germany,757,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,DK,Denmark,89,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,EE,Estonia,10,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,EL,Greece,1558,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,ES,Spain,76,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,FI,Finland,33,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,HR,Croatia,262,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,HU,Hungary,426,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,IE,Ireland,58,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,IS,Iceland,1,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,IT,Italy,3061,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,LT,Lithuania,120,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,LU,Luxembourg,7,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,LV,Latvia,77,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,MT,Malta,21,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,NL,Netherlands,212,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,NO,Norway,40,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,PL,Poland,433,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,PT,Portugal,152,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,RO,Romania,285,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,SE,Sweden,153,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,SI,Slovenia,52,
Antimicrobial resistance,Acinetobacter spp.|Aminoglycosides,Total tested isolates,N,2023,SK,Slovakia,76,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,2,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,3,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,2,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,1,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,7,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,2,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,6,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,15,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,1,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,1,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,1,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,5,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,2,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,4,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,1,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,2,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,AT,Austria,7,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,BE,Belgium,8,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,BG,Bulgaria,158,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,CY,Cyprus,116,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,CZ,Czechia,34,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,DE,Germany,26,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,DK,Denmark,2,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,EE,Estonia,3,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,EL,Greece,1500,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,ES,Spain,28,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,FI,Finland,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,HR,Croatia,254,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,HU,Hungary,198,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,IE,Ireland,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,IT,Italy,2351,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,LT,Lithuania,113,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,LV,Latvia,54,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,MT,Malta,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,NL,Netherlands,3,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,NO,Norway,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,PL,Poland,359,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,PT,Portugal,67,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,RO,Romania,292,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,SE,Sweden,3,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,SI,Slovenia,12,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,R - resistant isolates,N,2023,SK,Slovakia,36,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,AT,Austria,7.21649484,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,4.12371134,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,86.33879781,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,86.56716417,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,37.36263736,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,DE,Germany,3.1553398,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,2.22222222,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,-,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,EL,Greece,95.29860228,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,ES,Spain,39.43661971,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,FI,Finland,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,95.8490566,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,46.15384615,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,-,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,IT,Italy,75.88766946,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,92.62295081,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,-,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,70.12987012,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,MT,Malta,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,1.42857142,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,NO,Norway,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,PL,Poland,79.77777777,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,43.22580645,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,RO,Romania,86.9047619,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,1.92307692,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,23.07692307,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,47.36842105,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,AT,Austria,88,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,BE,Belgium,183,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,BG,Bulgaria,23,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,CY,Cyprus,18,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,CZ,Czechia,56,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,DE,Germany,791,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,DK,Denmark,88,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,EE,Estonia,11,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,EL,Greece,72,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,ES,Spain,43,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,FI,Finland,33,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,HR,Croatia,11,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,HU,Hungary,225,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,IE,Ireland,64,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,IS,Iceland,1,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,IT,Italy,732,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,LT,Lithuania,8,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,LU,Luxembourg,5,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,LV,Latvia,22,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,MT,Malta,21,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,NL,Netherlands,206,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,NO,Norway,41,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,PL,Poland,86,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,PT,Portugal,86,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,RO,Romania,40,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,SE,Sweden,152,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,SI,Slovenia,40,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,S - susceptible isolates,N,2023,SK,Slovakia,38,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,AT,Austria,97,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,BE,Belgium,194,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,BG,Bulgaria,183,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,CY,Cyprus,134,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,CZ,Czechia,91,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,DE,Germany,824,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,DK,Denmark,90,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,EE,Estonia,14,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,EL,Greece,1574,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,ES,Spain,71,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,FI,Finland,33,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,HR,Croatia,265,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,HU,Hungary,429,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,IE,Ireland,64,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,IS,Iceland,1,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,IT,Italy,3098,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,LT,Lithuania,122,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,LU,Luxembourg,5,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,LV,Latvia,77,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,MT,Malta,21,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,NL,Netherlands,210,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,NO,Norway,41,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,PL,Poland,450,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,PT,Portugal,155,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,RO,Romania,336,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,SE,Sweden,156,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,SI,Slovenia,52,
Antimicrobial resistance,Acinetobacter spp.|Carbapenems,Total tested isolates,N,2023,SK,Slovakia,76,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,AT,Austria,3,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,BE,Belgium,2,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,BG,Bulgaria,147,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,CY,Cyprus,110,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,CZ,Czechia,31,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,DE,Germany,15,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,DK,Denmark,2,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,EE,Estonia,2,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,EL,Greece,1356,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,ES,Spain,21,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,FI,Finland,0,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,HR,Croatia,237,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,HU,Hungary,158,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,IE,Ireland,0,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,IT,Italy,2162,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,LT,Lithuania,98,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,LU,Luxembourg,0,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,LV,Latvia,33,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,MT,Malta,0,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,NL,Netherlands,3,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,NO,Norway,0,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,PL,Poland,278,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,PT,Portugal,42,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,RO,Romania,230,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,SE,Sweden,2,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,SI,Slovenia,12,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",R - resistant isolates,N,2023,SK,Slovakia,33,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,AT,Austria,5.17241379,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,BE,Belgium,1.37931034,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,80.32786885,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,CY,Cyprus,82.70676691,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,CZ,Czechia,34.06593406,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,DE,Germany,1.98412698,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,DK,Denmark,2.27272727,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,EE,Estonia,-,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,EL,Greece,87.42746615,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,ES,Spain,30.4347826,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,FI,Finland,0,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,HR,Croatia,91.5057915,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,HU,Hungary,37.26415094,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,IE,Ireland,0,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,IS,Iceland,-,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,IT,Italy,72.11474316,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,LT,Lithuania,83.05084745,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,-,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,LV,Latvia,67.34693877,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,MT,Malta,0,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,NL,Netherlands,1.45631067,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,NO,Norway,0,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,PL,Poland,66.03325415,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,PT,Portugal,27.81456953,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,RO,Romania,81.56028368,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,SE,Sweden,1.30718954,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,SI,Slovenia,23.07692307,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)","R - resistant isolates, percentage  ",%,2023,SK,Slovakia,43.42105263,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,AT,Austria,58,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,BE,Belgium,145,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,BG,Bulgaria,183,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,CY,Cyprus,133,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,CZ,Czechia,91,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,DE,Germany,756,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,DK,Denmark,88,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,EE,Estonia,10,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,EL,Greece,1551,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,ES,Spain,69,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,FI,Finland,33,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,HR,Croatia,259,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,HU,Hungary,424,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,IE,Ireland,56,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,IS,Iceland,1,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,IT,Italy,2998,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,LT,Lithuania,118,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,LU,Luxembourg,5,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,LV,Latvia,49,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,MT,Malta,21,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,NL,Netherlands,206,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,NO,Norway,40,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,PL,Poland,421,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,PT,Portugal,151,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,RO,Romania,282,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,SE,Sweden,153,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,SI,Slovenia,52,
Antimicrobial resistance,"Acinetobacter spp.|Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)",Total tested isolates,N,2023,SK,Slovakia,76,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,AT,Austria,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,BE,Belgium,85.36853685,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,CY,Cyprus,87.52860411,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,CZ,Czechia,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,DE,Germany,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,DK,Denmark,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,EE,Estonia,95.3125,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,EL,Greece,57.02892199,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,ES,Spain,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,FI,Finland,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,FR,France,-,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,HR,Croatia,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,HU,Hungary,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,IE,Ireland,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,IS,Iceland,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,IT,Italy,99.92620704,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,LT,Lithuania,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,LV,Latvia,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,MT,Malta,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,NO,Norway,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,PL,Poland,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,PT,Portugal,98.33487511,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,RO,Romania,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,SE,Sweden,99.27007299,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness age,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,AT,Austria,98.85844748,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,BE,Belgium,93.06930693,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,CY,Cyprus,88.90160183,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,CZ,Czechia,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,DE,Germany,87.25398313,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,DK,Denmark,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,EE,Estonia,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,EL,Greece,71.92813321,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,ES,Spain,98.70609981,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,FI,Finland,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,FR,France,-,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,HR,Croatia,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,HU,Hungary,69.91062562,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,IE,Ireland,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,IS,Iceland,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,IT,Italy,99.55724225,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,LT,Lithuania,0,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,LV,Latvia,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,MT,Malta,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,NO,Norway,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,PL,Poland,99.61538461,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,PT,Portugal,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,RO,Romania,98.64612511,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,SE,Sweden,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Acinetobacter spp.|Data quality,Completeness gender,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,77,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,163,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,17,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,3,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,56,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,758,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,59,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,8,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,47,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,7,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,12,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,9,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,191,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,56,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,1,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,627,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,9,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,4,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,3,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,8,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,196,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,41,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,43,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,74,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,37,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,152,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,39,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,39,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,AT,Austria,5,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,BE,Belgium,17,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,BG,Bulgaria,166,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,CY,Cyprus,117,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,CZ,Czechia,35,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,DE,Germany,38,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,DK,Denmark,8,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,EE,Estonia,3,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,EL,Greece,1489,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,ES,Spain,34,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,FI,Finland,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,HR,Croatia,253,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,HU,Hungary,210,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,IE,Ireland,1,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,IT,Italy,2341,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,LT,Lithuania,110,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,LU,Luxembourg,1,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,LV,Latvia,41,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,MT,Malta,1,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,NL,Netherlands,11,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,NO,Norway,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,PL,Poland,378,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,PT,Portugal,72,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,RO,Romania,293,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,SE,Sweden,4,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,SI,Slovenia,13,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,R - resistant isolates,N,2023,SK,Slovakia,37,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,AT,Austria,5.74712643,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,8.67346938,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,90.71038251,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,86.66666666,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,38.46153846,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,DE,Germany,4.61725394,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,8.98876404,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,-,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,EL,Greece,95.08301404,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,ES,Spain,43.03797468,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,FI,Finland,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,96.56488549,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,48.95104895,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,1.61290322,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,-,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,IT,Italy,76.93066053,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,92.43697478,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,-,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,83.67346938,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,MT,Malta,4.76190476,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,5.21327014,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,NO,Norway,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,PL,Poland,85.71428571,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,46.15384615,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,RO,Romania,87.72455089,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,2.56410256,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,25,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,48.68421052,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,AT,Austria,5,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,BE,Belgium,16,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,CY,Cyprus,15,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,CZ,Czechia,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,DE,Germany,27,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,DK,Denmark,22,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,EE,Estonia,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,EL,Greece,30,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,ES,Spain,38,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,FI,Finland,21,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,HR,Croatia,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,HU,Hungary,28,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,IE,Ireland,5,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,IT,Italy,75,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,LT,Lithuania,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,LU,Luxembourg,2,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,LV,Latvia,5,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,MT,Malta,12,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,NL,Netherlands,4,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,NO,Norway,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,PL,Poland,20,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,PT,Portugal,10,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,RO,Romania,4,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,SE,Sweden,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,SI,Slovenia,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,S - susceptible isolates,N,2023,SK,Slovakia,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,AT,Austria,87,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,BE,Belgium,196,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,BG,Bulgaria,183,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,CY,Cyprus,135,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,CZ,Czechia,91,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,DE,Germany,823,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,DK,Denmark,89,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,EE,Estonia,11,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,EL,Greece,1566,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,ES,Spain,79,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,FI,Finland,33,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,HR,Croatia,262,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,HU,Hungary,429,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,IE,Ireland,62,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,IS,Iceland,1,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,IT,Italy,3043,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,LT,Lithuania,119,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,LU,Luxembourg,7,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,LV,Latvia,49,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,MT,Malta,21,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,NL,Netherlands,211,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,NO,Norway,41,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,PL,Poland,441,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,PT,Portugal,156,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,RO,Romania,334,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,SE,Sweden,156,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,SI,Slovenia,52,
Antimicrobial resistance,Acinetobacter spp.|Fluoroquinolones,Total tested isolates,N,2023,SK,Slovakia,76,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,2,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,1,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,4,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,6,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,1,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,27,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,1,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,4,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,1,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,1,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,AT,Austria,36,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,BE,Belgium,2,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,CY,Cyprus,1,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,CZ,Czechia,10,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,DE,Germany,64,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,DK,Denmark,1,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,EE,Estonia,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,EL,Greece,28,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,ES,Spain,6,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,FI,Finland,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,HR,Croatia,7,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,HU,Hungary,7,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,IE,Ireland,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,IT,Italy,95,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,LT,Lithuania,6,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,LV,Latvia,6,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,MT,Malta,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,NL,Netherlands,1,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,NO,Norway,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,PL,Poland,26,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,PT,Portugal,12,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,RO,Romania,7,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,SE,Sweden,2,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,SI,Slovenia,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,R - resistant isolates,N,2023,SK,Slovakia,2,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,AT,Austria,4.35308343,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,0.30534351,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,0.67567567,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,1.41242937,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,DE,Germany,1.26858275,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,0.15576323,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,EL,Greece,2.81407035,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,ES,Spain,0.402955,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,FI,Finland,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,3.125,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,0.79545454,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,IT,Italy,1.17939168,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,3.7037037,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,5.26315789,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,MT,Malta,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,0.08190008,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,NO,Norway,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,PL,Poland,2.6395939,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,1.15052732,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,RO,Romania,2.24358974,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,0.12861736,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,0.95238095,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,AT,Austria,791,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,BE,Belgium,651,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,BG,Bulgaria,168,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,CY,Cyprus,147,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,CZ,Czechia,697,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,DE,Germany,4977,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,DK,Denmark,641,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,EE,Estonia,125,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,EL,Greece,961,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,ES,Spain,1482,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,FI,Finland,367,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,HR,Croatia,217,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,HU,Hungary,873,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,IE,Ireland,361,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,IS,Iceland,33,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,IT,Italy,7933,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,LT,Lithuania,156,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,LU,Luxembourg,81,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,LV,Latvia,108,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,MT,Malta,30,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,NL,Netherlands,1220,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,NO,Norway,608,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,PL,Poland,959,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,PT,Portugal,1030,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,RO,Romania,305,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,SE,Sweden,1549,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,SI,Slovenia,176,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,S - susceptible isolates,N,2023,SK,Slovakia,207,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,AT,Austria,827,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,BE,Belgium,655,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,BG,Bulgaria,168,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,CY,Cyprus,148,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,CZ,Czechia,708,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,DE,Germany,5045,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,DK,Denmark,642,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,EE,Estonia,125,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,EL,Greece,995,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,ES,Spain,1489,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,FI,Finland,367,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,HR,Croatia,224,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,HU,Hungary,880,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,IE,Ireland,361,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,IS,Iceland,33,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,IT,Italy,8055,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,LT,Lithuania,162,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,LU,Luxembourg,81,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,LV,Latvia,114,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,MT,Malta,30,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,NL,Netherlands,1221,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,NO,Norway,608,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,PL,Poland,985,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,PT,Portugal,1043,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,RO,Romania,312,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,SE,Sweden,1555,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,SI,Slovenia,177,
Antimicrobial resistance,Enterococcus faecalis|Aminopenicillins,Total tested isolates,N,2023,SK,Slovakia,210,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,AT,Austria,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,BE,Belgium,85.76937909,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,CY,Cyprus,82.94036061,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,CZ,Czechia,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,DE,Germany,99.9883273,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,DK,Denmark,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,EE,Estonia,99.01768172,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,EL,Greece,57.70261909,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,ES,Spain,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,FI,Finland,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,FR,France,-,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,HR,Croatia,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,HU,Hungary,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,IE,Ireland,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,IS,Iceland,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,IT,Italy,99.86607015,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,LI,Liechtenstein,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,LT,Lithuania,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,LV,Latvia,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,MT,Malta,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,NO,Norway,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,PL,Poland,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,PT,Portugal,97.4753227,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,RO,Romania,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,SE,Sweden,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness age,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,AT,Austria,98.59989229,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,BE,Belgium,94.02236791,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,CY,Cyprus,85.71428571,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,CZ,Czechia,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,DE,Germany,87.68919497,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,DK,Denmark,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,EE,Estonia,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,EL,Greece,74.63394514,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,ES,Spain,95.04400812,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,FI,Finland,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,FR,France,-,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,HR,Croatia,98.79275653,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,HU,Hungary,78.95970009,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,IE,Ireland,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,IS,Iceland,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,IT,Italy,99.68939674,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,LI,Liechtenstein,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,LT,Lithuania,0,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,LV,Latvia,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,MT,Malta,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,NO,Norway,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,PL,Poland,98.02798982,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,PT,Portugal,99.90508731,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,RO,Romania,97.2164231,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,SE,Sweden,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Enterococcus faecalis|Data quality,Completeness gender,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,AT,Austria,40,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,BE,Belgium,33,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,BG,Bulgaria,65,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,CY,Cyprus,15,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,CZ,Czechia,187,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,DE,Germany,473,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,DK,Denmark,1,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,EE,Estonia,7,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,EL,Greece,80,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,ES,Spain,301,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,FI,Finland,0,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,HR,Croatia,66,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,HU,Hungary,316,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,IE,Ireland,46,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,IS,Iceland,6,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,IT,Italy,1197,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,LT,Lithuania,29,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,LU,Luxembourg,9,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,LV,Latvia,98,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,MT,Malta,2,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,NL,Netherlands,83,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,NO,Norway,6,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,PL,Poland,431,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,PT,Portugal,152,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,RO,Romania,131,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,SE,Sweden,61,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,SI,Slovenia,19,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,R - resistant isolates,N,2023,SK,Slovakia,29,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,AT,Austria,11.9760479,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,9.09090909,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,38.69047619,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,11.9047619,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,26.44978783,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,DE,Germany,11.08507147,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,-,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,5.6,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,EL,Greece,10.49868766,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,ES,Spain,24.77366255,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,FI,Finland,-,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,30.41474654,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,33.40380549,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,15.38461538,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,18.18181818,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,IT,Italy,34.50562121,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,29.29292929,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,13.84615384,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,98.98989898,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,MT,Malta,6.89655172,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,14.40972222,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,NO,Norway,4.34782608,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,PL,Poland,47.15536105,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,18.40193704,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,RO,Romania,46.78571428,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,6.67396061,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,10.91954022,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,13.94230769,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,AT,Austria,334,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,BE,Belgium,363,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,BG,Bulgaria,168,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,CY,Cyprus,126,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,CZ,Czechia,707,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,DE,Germany,4267,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,DK,Denmark,3,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,EE,Estonia,125,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,EL,Greece,762,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,ES,Spain,1215,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,FI,Finland,0,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,HR,Croatia,217,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,HU,Hungary,946,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,IE,Ireland,299,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,IS,Iceland,33,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,IT,Italy,3469,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,LT,Lithuania,99,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,LU,Luxembourg,65,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,LV,Latvia,99,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,MT,Malta,29,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,NL,Netherlands,576,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,NO,Norway,138,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,PL,Poland,914,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,PT,Portugal,826,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,RO,Romania,280,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,SE,Sweden,914,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,SI,Slovenia,174,
Antimicrobial resistance,Enterococcus faecalis|High-level gentamicin,Total tested isolates,N,2023,SK,Slovakia,208,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,AT,Austria,1,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,BE,Belgium,2,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,BG,Bulgaria,2,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,CY,Cyprus,4,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,CZ,Czechia,4,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,DE,Germany,3,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,DK,Denmark,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,EE,Estonia,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,EL,Greece,68,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,ES,Spain,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,FI,Finland,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,HR,Croatia,2,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,HU,Hungary,20,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,IE,Ireland,2,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,IT,Italy,146,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,LT,Lithuania,6,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,LV,Latvia,7,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,MT,Malta,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,NL,Netherlands,2,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,NO,Norway,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,PL,Poland,53,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,PT,Portugal,6,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,RO,Romania,14,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,SE,Sweden,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,SI,Slovenia,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,R - resistant isolates,N,2023,SK,Slovakia,2,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,AT,Austria,0.11198208,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,0.34423407,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,1.19047619,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,2.68456375,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,0.56497175,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,DE,Germany,0.05290072,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,EL,Greece,6.51965484,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,ES,Spain,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,FI,Finland,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,0.90497737,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,2.11640211,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,0.55096418,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,IT,Italy,1.8291155,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,3.7037037,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,6.08695652,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,MT,Malta,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,0.16736401,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,NO,Norway,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,PL,Poland,5.33736153,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,0.57859209,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,RO,Romania,4.54545454,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,0.94786729,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,AT,Austria,892,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,BE,Belgium,579,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,BG,Bulgaria,166,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,CY,Cyprus,145,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,CZ,Czechia,704,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,DE,Germany,5668,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,DK,Denmark,600,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,EE,Estonia,127,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,EL,Greece,975,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,ES,Spain,1561,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,FI,Finland,460,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,HR,Croatia,219,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,HU,Hungary,925,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,IE,Ireland,361,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,IS,Iceland,33,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,IT,Italy,7836,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,LT,Lithuania,156,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,LU,Luxembourg,81,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,LV,Latvia,108,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,MT,Malta,30,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,NL,Netherlands,1193,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,NO,Norway,600,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,PL,Poland,940,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,PT,Portugal,1031,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,RO,Romania,294,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,SE,Sweden,1605,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,SI,Slovenia,177,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,S - susceptible isolates,N,2023,SK,Slovakia,209,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,AT,Austria,893,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,BE,Belgium,581,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,BG,Bulgaria,168,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,CY,Cyprus,149,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,CZ,Czechia,708,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,DE,Germany,5671,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,DK,Denmark,600,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,EE,Estonia,127,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,EL,Greece,1043,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,ES,Spain,1561,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,FI,Finland,460,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,HR,Croatia,221,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,HU,Hungary,945,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,IE,Ireland,363,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,IS,Iceland,33,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,IT,Italy,7982,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,LT,Lithuania,162,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,LU,Luxembourg,81,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,LV,Latvia,115,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,MT,Malta,30,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,NL,Netherlands,1195,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,NO,Norway,600,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,PL,Poland,993,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,PT,Portugal,1037,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,RO,Romania,308,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,SE,Sweden,1605,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,SI,Slovenia,177,
Antimicrobial resistance,Enterococcus faecalis|Vancomycin,Total tested isolates,N,2023,SK,Slovakia,211,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,1,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,3,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,2,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,2,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,1,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,7,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,2,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,38,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,3,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,3,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,2,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,1,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,2,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,1,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,AT,Austria,537,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,BE,Belgium,254,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,BG,Bulgaria,128,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,CY,Cyprus,118,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,CZ,Czechia,379,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,DE,Germany,4111,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,DK,Denmark,558,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,EE,Estonia,47,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,EL,Greece,1169,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,ES,Spain,911,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,FI,Finland,131,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,HR,Croatia,136,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,HU,Hungary,381,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,IE,Ireland,585,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,IS,Iceland,34,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,IT,Italy,5383,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,LT,Lithuania,151,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,LU,Luxembourg,67,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,LV,Latvia,50,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,MT,Malta,22,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,NL,Netherlands,861,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,NO,Norway,197,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,PL,Poland,680,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,PT,Portugal,460,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,RO,Romania,159,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,SE,Sweden,827,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,SI,Slovenia,155,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,R - resistant isolates,N,2023,SK,Slovakia,119,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,AT,Austria,91.32653061,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,80.63492063,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,93.65079365,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,94.51371571,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,DE,Germany,93.51683348,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,92.8452579,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,88.67924528,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,EL,Greece,95.97701149,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,ES,Spain,89.0518084,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,FI,Finland,80.86419753,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,90.66666666,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,98.4496124,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,96.0591133,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,87.17948717,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,IT,Italy,89.6568954,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,96.79487179,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,90.54054054,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,89.28571428,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,MT,Malta,88,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,87.14574898,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,NO,Norway,77.55905511,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,PL,Poland,95.50561797,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,87.78625954,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,RO,Romania,88.82681564,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,86.23566214,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,90.64327485,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,97.5409836,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,AT,Austria,50,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,BE,Belgium,58,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,CY,Cyprus,6,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,CZ,Czechia,22,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,DE,Germany,283,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,DK,Denmark,43,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,EE,Estonia,5,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,EL,Greece,42,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,ES,Spain,110,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,FI,Finland,31,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,HR,Croatia,14,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,HU,Hungary,6,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,IE,Ireland,24,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,IS,Iceland,5,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,IT,Italy,583,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,LT,Lithuania,2,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,LU,Luxembourg,7,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,LV,Latvia,6,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,MT,Malta,3,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,NL,Netherlands,124,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,NO,Norway,55,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,PL,Poland,32,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,PT,Portugal,64,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,RO,Romania,19,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,SE,Sweden,130,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,SI,Slovenia,16,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,S - susceptible isolates,N,2023,SK,Slovakia,2,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,AT,Austria,588,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,BE,Belgium,315,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,BG,Bulgaria,128,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,CY,Cyprus,126,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,CZ,Czechia,401,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,DE,Germany,4396,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,DK,Denmark,601,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,EE,Estonia,53,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,EL,Greece,1218,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,ES,Spain,1023,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,FI,Finland,162,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,HR,Croatia,150,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,HU,Hungary,387,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,IE,Ireland,609,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,IS,Iceland,39,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,IT,Italy,6004,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,LT,Lithuania,156,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,LU,Luxembourg,74,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,LV,Latvia,56,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,MT,Malta,25,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,NL,Netherlands,988,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,NO,Norway,254,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,PL,Poland,712,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,PT,Portugal,524,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,RO,Romania,179,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,SE,Sweden,959,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,SI,Slovenia,171,
Antimicrobial resistance,Enterococcus faecium|Aminopenicillins,Total tested isolates,N,2023,SK,Slovakia,122,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,AT,Austria,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,BE,Belgium,87.90544255,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,CY,Cyprus,83.49673202,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,CZ,Czechia,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,DE,Germany,99.98248303,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,DK,Denmark,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,EE,Estonia,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,EL,Greece,59.42324003,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,ES,Spain,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,FI,Finland,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,FR,France,-,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,HR,Croatia,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,HU,Hungary,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,IE,Ireland,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,IS,Iceland,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,IT,Italy,99.82988053,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,LT,Lithuania,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,LV,Latvia,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,MT,Malta,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,NO,Norway,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,PL,Poland,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,PT,Portugal,98.66361206,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,RO,Romania,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,SE,Sweden,99.88088147,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness age,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,AT,Austria,97.38850944,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,BE,Belgium,95.16217702,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,CY,Cyprus,85.13071895,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,CZ,Czechia,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,DE,Germany,90.09415371,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,DK,Denmark,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,EE,Estonia,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,EL,Greece,73.6726039,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,ES,Spain,96.67379887,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,FI,Finland,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,FR,France,-,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,HR,Croatia,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,HU,Hungary,86.82553956,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,IE,Ireland,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,IS,Iceland,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,IT,Italy,99.59171329,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,LT,Lithuania,0,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,LV,Latvia,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,MT,Malta,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,NO,Norway,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,PL,Poland,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,PT,Portugal,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,RO,Romania,98.83040935,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,SE,Sweden,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Enterococcus faecium|Data quality,Completeness gender,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,AT,Austria,78,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,BE,Belgium,85,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,BG,Bulgaria,92,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,CY,Cyprus,25,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,CZ,Czechia,201,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,DE,Germany,2130,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,DK,Denmark,10,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,EE,Estonia,8,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,EL,Greece,219,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,ES,Spain,176,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,FI,Finland,0,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,HR,Croatia,64,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,HU,Hungary,293,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,IE,Ireland,322,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,IS,Iceland,13,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,IT,Italy,1529,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,LT,Lithuania,34,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,LU,Luxembourg,25,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,LV,Latvia,44,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,MT,Malta,12,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,NL,Netherlands,380,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,NO,Norway,41,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,PL,Poland,347,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,PT,Portugal,148,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,RO,Romania,118,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,SE,Sweden,81,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,SI,Slovenia,23,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,R - resistant isolates,N,2023,SK,Slovakia,65,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,AT,Austria,32.9113924,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,34.55284552,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,71.875,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,23.36448598,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,50.12468827,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,DE,Germany,58.05396565,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,-,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,10.52631578,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,EL,Greece,23.57373519,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,ES,Spain,21.05263157,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,FI,Finland,-,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,44.13793103,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,65.25612472,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,62.76803118,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,33.33333333,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,IT,Italy,56.65061133,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,47.88732394,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,41.66666666,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,97.77777777,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,MT,Malta,48,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,74.95069033,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,NO,Norway,50.61728395,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,PL,Poland,52.97709923,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,36.09756097,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,RO,Romania,71.95121951,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,13.96551724,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,13.69047619,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,54.62184873,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,AT,Austria,237,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,BE,Belgium,246,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,BG,Bulgaria,128,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,CY,Cyprus,107,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,CZ,Czechia,401,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,DE,Germany,3669,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,DK,Denmark,10,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,EE,Estonia,76,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,EL,Greece,929,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,ES,Spain,836,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,FI,Finland,0,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,HR,Croatia,145,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,HU,Hungary,449,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,IE,Ireland,513,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,IS,Iceland,39,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,IT,Italy,2699,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,LT,Lithuania,71,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,LU,Luxembourg,60,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,LV,Latvia,45,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,MT,Malta,25,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,NL,Netherlands,507,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,NO,Norway,81,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,PL,Poland,655,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,PT,Portugal,410,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,RO,Romania,164,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,SE,Sweden,580,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,SI,Slovenia,168,
Antimicrobial resistance,Enterococcus faecium|High-level gentamicin,Total tested isolates,N,2023,SK,Slovakia,119,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,7,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,AT,Austria,18,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,BE,Belgium,17,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,BG,Bulgaria,7,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,CY,Cyprus,68,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,CZ,Czechia,83,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,DE,Germany,629,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,DK,Denmark,66,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,EE,Estonia,9,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,EL,Greece,742,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,ES,Spain,44,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,FI,Finland,1,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,HR,Croatia,35,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,HU,Hungary,171,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,IE,Ireland,129,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,IT,Italy,1957,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,LT,Lithuania,95,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,LU,Luxembourg,5,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,LV,Latvia,14,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,MT,Malta,9,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,NL,Netherlands,5,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,NO,Norway,2,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,PL,Poland,301,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,PT,Portugal,54,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,RO,Romania,73,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,SE,Sweden,7,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,SI,Slovenia,8,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,R - resistant isolates,N,2023,SK,Slovakia,32,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,AT,Austria,3.05602716,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,3.74449339,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,5.46875,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,53.54330708,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,20.69825436,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,DE,Germany,12.74311183,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,10.83743842,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,11.68831168,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,EL,Greece,58.60979462,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,ES,Spain,4.02930402,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,FI,Finland,0.51020408,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,23.48993288,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,38.16964285,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,21.04404567,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,IT,Italy,32.52451387,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,60.89743589,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,6.75675675,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,22.95081967,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,MT,Malta,36,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,0.50658561,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,NO,Norway,0.79051383,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,PL,Poland,41.34615384,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,10.34482758,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,RO,Romania,41.24293785,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,0.7,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,4.67836257,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,22.69503546,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,AT,Austria,571,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,BE,Belgium,437,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,BG,Bulgaria,121,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,CY,Cyprus,59,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,CZ,Czechia,318,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,DE,Germany,4307,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,DK,Denmark,543,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,EE,Estonia,68,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,EL,Greece,524,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,ES,Spain,1041,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,FI,Finland,195,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,HR,Croatia,114,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,HU,Hungary,277,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,IE,Ireland,484,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,IS,Iceland,39,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,IT,Italy,4060,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,LT,Lithuania,61,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,LU,Luxembourg,69,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,LV,Latvia,47,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,MT,Malta,16,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,NL,Netherlands,982,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,NO,Norway,251,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,PL,Poland,427,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,PT,Portugal,468,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,RO,Romania,104,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,SE,Sweden,993,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,SI,Slovenia,163,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,S - susceptible isolates,N,2023,SK,Slovakia,109,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,AT,Austria,589,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,BE,Belgium,454,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,BG,Bulgaria,128,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,CY,Cyprus,127,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,CZ,Czechia,401,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,DE,Germany,4936,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,DK,Denmark,609,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,EE,Estonia,77,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,EL,Greece,1266,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,ES,Spain,1092,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,FI,Finland,196,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,HR,Croatia,149,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,HU,Hungary,448,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,IE,Ireland,613,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,IS,Iceland,39,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,IT,Italy,6017,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,LT,Lithuania,156,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,LU,Luxembourg,74,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,LV,Latvia,61,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,MT,Malta,25,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,NL,Netherlands,987,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,NO,Norway,253,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,PL,Poland,728,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,PT,Portugal,522,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,RO,Romania,177,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,SE,Sweden,1000,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,SI,Slovenia,171,
Antimicrobial resistance,Enterococcus faecium|Vancomycin,Total tested isolates,N,2023,SK,Slovakia,141,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,163,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,2,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,5,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,14,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,2,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,6,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,1,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,10,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,1,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,1,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,1,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,AT,Austria,252,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,BE,Belgium,306,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,BG,Bulgaria,87,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,CY,Cyprus,61,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,CZ,Czechia,380,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,DE,Germany,1800,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,DK,Denmark,262,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,EE,Estonia,53,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,EL,Greece,377,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,ES,Spain,1182,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,FI,Finland,205,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,HR,Croatia,231,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,HU,Hungary,407,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,IE,Ireland,272,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,IS,Iceland,14,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,IT,Italy,4578,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,LT,Lithuania,167,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,LU,Luxembourg,46,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,LV,Latvia,68,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,MT,Malta,43,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,NL,Netherlands,407,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,NO,Norway,220,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,PL,Poland,393,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,PT,Portugal,844,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,RO,Romania,110,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,SE,Sweden,660,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,SI,Slovenia,114,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,R - resistant isolates,N,2023,SK,Slovakia,96,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,AT,Austria,5.35600425,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,7.5761327,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,28.43137254,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,18.48484848,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,9.76361767,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,DE,Germany,5.34632291,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,4.4870697,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,4.93482309,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,EL,Greece,20.62363238,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,ES,Spain,12.30096784,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,FI,Finland,4.83376562,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,17.75557263,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,14.77850399,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,8.74316939,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,5.42635658,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,IT,Italy,16.01035182,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,11.33740665,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,9.97830802,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,14.87964989,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,MT,Malta,10.33653846,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,5.19066445,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,NO,Norway,5.52347476,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,PL,Poland,14.13669064,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,13.17309193,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,RO,Romania,12.716763,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,6.16016427,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,6.95546064,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,13.81294964,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,AT,Austria,4290,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,BE,Belgium,3733,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,BG,Bulgaria,219,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,CY,Cyprus,269,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,CZ,Czechia,3512,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,DE,Germany,31866,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,DK,Denmark,5572,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,EE,Estonia,1021,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,EL,Greece,1451,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,ES,Spain,8413,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,FI,Finland,4036,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,HR,Croatia,1070,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,HU,Hungary,2347,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,IE,Ireland,2837,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,IS,Iceland,244,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,IT,Italy,24010,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,LI,Liechtenstein,8,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,LT,Lithuania,1306,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,LU,Luxembourg,415,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,LV,Latvia,389,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,MT,Malta,372,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,NL,Netherlands,7424,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,NO,Norway,3762,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,PL,Poland,2387,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,PT,Portugal,5562,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,RO,Romania,755,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,SE,Sweden,10053,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,SI,Slovenia,1525,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,S - susceptible isolates,N,2023,SK,Slovakia,599,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,AT,Austria,4705,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,BE,Belgium,4039,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,BG,Bulgaria,306,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,CY,Cyprus,330,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,CZ,Czechia,3892,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,DE,Germany,33668,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,DK,Denmark,5839,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,EE,Estonia,1074,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,EL,Greece,1828,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,ES,Spain,9609,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,FI,Finland,4241,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,HR,Croatia,1301,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,HU,Hungary,2754,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,IE,Ireland,3111,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,IS,Iceland,258,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,IT,Italy,28594,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,LI,Liechtenstein,8,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,LT,Lithuania,1473,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,LU,Luxembourg,461,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,LV,Latvia,457,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,MT,Malta,416,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,NL,Netherlands,7841,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,NO,Norway,3983,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,PL,Poland,2780,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,PT,Portugal,6407,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,RO,Romania,865,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,SE,Sweden,10714,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,SI,Slovenia,1639,
Antimicrobial resistance,Escherichia coli|Aminoglycosides,Total tested isolates,N,2023,SK,Slovakia,695,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,2,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,77,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,711,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,2,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,3,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,29,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,2,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,65,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,72,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,11,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,AT,Austria,2268,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,BE,Belgium,2587,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,BG,Bulgaria,205,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,CY,Cyprus,226,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,CZ,Czechia,2007,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,DE,Germany,15878,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,DK,Denmark,2346,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,EE,Estonia,198,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,EL,Greece,913,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,ES,Spain,5049,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,FI,Finland,830,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,HR,Croatia,735,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,HU,Hungary,1445,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,IE,Ireland,1962,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,IS,Iceland,136,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,IT,Italy,5659,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,LI,Liechtenstein,3,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,LT,Lithuania,906,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,LU,Luxembourg,238,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,LV,Latvia,104,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,MT,Malta,260,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,NL,Netherlands,3211,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,NO,Norway,1468,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,PL,Poland,627,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,PT,Portugal,3220,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,RO,Romania,469,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,SE,Sweden,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,SI,Slovenia,803,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,R - resistant isolates,N,2023,SK,Slovakia,400,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,AT,Austria,46.42784032,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,55.65834767,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,66.99346405,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,68.90243902,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,51.56731757,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,DE,Germany,46.33612513,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,40.4552509,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,38.07692307,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,EL,Greece,57.82140595,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,ES,Spain,57.42067553,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,FI,Finland,32.5490196,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,57.19844357,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,57.36403334,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,62.98555377,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,52.71317829,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,IT,Italy,63.22198637,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,61.34055517,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,51.62689804,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,50,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,MT,Malta,62.5,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,40.98800102,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,NO,Norway,36.85664072,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,PL,Poland,65.58577405,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,54.36434239,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,RO,Romania,61.71052631,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,-,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,48.99328859,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,58.47953216,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,AT,Austria,2615,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,BE,Belgium,1984,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,BG,Bulgaria,101,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,CY,Cyprus,102,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,CZ,Czechia,1885,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,DE,Germany,17678,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,DK,Denmark,3451,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,EE,Estonia,319,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,EL,Greece,666,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,ES,Spain,3715,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,FI,Finland,1720,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,HR,Croatia,550,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,HU,Hungary,1074,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,IE,Ireland,1153,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,IS,Iceland,122,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,IT,Italy,3290,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,LI,Liechtenstein,5,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,LT,Lithuania,571,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,LU,Luxembourg,223,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,LV,Latvia,104,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,MT,Malta,156,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,NL,Netherlands,4558,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,NO,Norway,2443,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,PL,Poland,329,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,PT,Portugal,2692,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,RO,Romania,291,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,SE,Sweden,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,SI,Slovenia,836,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,S - susceptible isolates,N,2023,SK,Slovakia,284,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,AT,Austria,4885,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,BE,Belgium,4648,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,BG,Bulgaria,306,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,CY,Cyprus,328,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,CZ,Czechia,3892,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,DE,Germany,34267,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,DK,Denmark,5799,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,EE,Estonia,520,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,EL,Greece,1579,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,ES,Spain,8793,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,FI,Finland,2550,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,HR,Croatia,1285,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,HU,Hungary,2519,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,IE,Ireland,3115,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,IS,Iceland,258,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,IT,Italy,8951,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,LI,Liechtenstein,8,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,LT,Lithuania,1477,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,LU,Luxembourg,461,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,LV,Latvia,208,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,MT,Malta,416,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,NL,Netherlands,7834,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,NO,Norway,3983,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,PL,Poland,956,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,PT,Portugal,5923,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,RO,Romania,760,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,SE,Sweden,0,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,SI,Slovenia,1639,
Antimicrobial resistance,Escherichia coli|Aminopenicillins,Total tested isolates,N,2023,SK,Slovakia,684,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,3,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,4,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,1,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,7,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,4,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,6,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,2,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,4,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,25,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,1,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,2,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,39,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,1,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,1,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,1,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,1,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,6,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,2,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,3,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,1,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,AT,Austria,7,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,BE,Belgium,4,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,BG,Bulgaria,1,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,CY,Cyprus,3,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,CZ,Czechia,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,DE,Germany,16,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,DK,Denmark,2,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,EE,Estonia,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,EL,Greece,29,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,ES,Spain,5,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,FI,Finland,1,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,HR,Croatia,2,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,HU,Hungary,6,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,IE,Ireland,2,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,IT,Italy,119,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,LT,Lithuania,1,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,LU,Luxembourg,1,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,LV,Latvia,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,MT,Malta,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,NL,Netherlands,7,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,NO,Norway,2,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,PL,Poland,6,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,PT,Portugal,33,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,RO,Romania,18,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,SE,Sweden,4,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,SI,Slovenia,1,
Antimicrobial resistance,Escherichia coli|Carbapenems,R - resistant isolates,N,2023,SK,Slovakia,1,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,AT,Austria,0.13081666,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,0.08067769,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,0.32679738,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,0.90634441,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,DE,Germany,0.0449148,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,0.03683241,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,EL,Greece,1.55329405,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,ES,Spain,0.05450779,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,FI,Finland,0.02343017,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,0.15360983,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,0.22321428,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,0.0651678,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,IT,Italy,0.43080041,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,0.06765899,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,0.21691973,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,MT,Malta,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,0.08997429,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,NO,Norway,0.0502008,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,PL,Poland,0.20229265,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,0.53372149,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,RO,Romania,1.82741116,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,0.03733432,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,0.06101281,
Antimicrobial resistance,Escherichia coli|Carbapenems,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,0.14367816,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,AT,Austria,5341,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,BE,Belgium,4950,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,BG,Bulgaria,305,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,CY,Cyprus,327,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,CZ,Czechia,1839,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,DE,Germany,35603,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,DK,Denmark,5422,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,EE,Estonia,892,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,EL,Greece,1834,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,ES,Spain,9143,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,FI,Finland,4266,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,HR,Croatia,1298,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,HU,Hungary,2682,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,IE,Ireland,3067,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,IS,Iceland,258,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,IT,Italy,27465,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,LI,Liechtenstein,8,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,LT,Lithuania,1477,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,LU,Luxembourg,459,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,LV,Latvia,455,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,MT,Malta,416,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,NL,Netherlands,7772,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,NO,Norway,3981,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,PL,Poland,2959,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,PT,Portugal,6144,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,RO,Romania,965,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,SE,Sweden,10707,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,SI,Slovenia,1638,
Antimicrobial resistance,Escherichia coli|Carbapenems,S - susceptible isolates,N,2023,SK,Slovakia,694,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,AT,Austria,5351,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,BE,Belgium,4958,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,BG,Bulgaria,306,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,CY,Cyprus,331,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,CZ,Czechia,1846,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,DE,Germany,35623,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,DK,Denmark,5430,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,EE,Estonia,894,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,EL,Greece,1867,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,ES,Spain,9173,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,FI,Finland,4268,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,HR,Croatia,1302,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,HU,Hungary,2688,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,IE,Ireland,3069,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,IS,Iceland,258,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,IT,Italy,27623,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,LI,Liechtenstein,8,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,LT,Lithuania,1478,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,LU,Luxembourg,461,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,LV,Latvia,455,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,MT,Malta,416,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,NL,Netherlands,7780,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,NO,Norway,3984,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,PL,Poland,2966,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,PT,Portugal,6183,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,RO,Romania,985,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,SE,Sweden,10714,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,SI,Slovenia,1639,
Antimicrobial resistance,Escherichia coli|Carbapenems,Total tested isolates,N,2023,SK,Slovakia,696,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,AT,Austria,99,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,BE,Belgium,107,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,BG,Bulgaria,54,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,CY,Cyprus,42,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,CZ,Czechia,189,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,DE,Germany,685,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,DK,Denmark,70,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,EE,Estonia,20,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,EL,Greece,205,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,ES,Spain,563,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,FI,Finland,90,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,HR,Croatia,143,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,HU,Hungary,254,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,IE,Ireland,99,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,IS,Iceland,8,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,IT,Italy,2850,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,LT,Lithuania,99,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,LU,Luxembourg,16,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,LV,Latvia,58,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,MT,Malta,23,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,NL,Netherlands,168,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,NO,Norway,53,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,PL,Poland,254,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,PT,Portugal,406,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,RO,Romania,51,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,SE,Sweden,231,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,SI,Slovenia,49,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,SK,Slovakia,72,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,AT,Austria,2.20539095,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,BE,Belgium,2.65311182,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,17.64705882,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,CY,Cyprus,12.72727272,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,CZ,Czechia,4.85986114,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,DE,Germany,2.0386298,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,DK,Denmark,1.33664311,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,EE,Estonia,1.92307692,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,EL,Greece,12.03758073,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,ES,Spain,6.09835355,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,FI,Finland,2.12916962,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,HR,Croatia,11.08527131,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,HU,Hungary,9.31768158,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,IE,Ireland,3.24377457,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,IS,Iceland,3.10077519,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,IT,Italy,10.22384847,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,LT,Lithuania,6.84647302,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,3.47071583,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,LV,Latvia,12.94642857,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,MT,Malta,5.52884615,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,NL,Netherlands,2.14395099,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,NO,Norway,1.33501259,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,PL,Poland,9.24308588,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,PT,Portugal,6.35865309,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,RO,Romania,6.00706713,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,SE,Sweden,2.16596343,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,SI,Slovenia,2.98962782,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,SK,Slovakia,10.40462427,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,AT,Austria,4489,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,BE,Belgium,4033,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,BG,Bulgaria,306,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,CY,Cyprus,330,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,CZ,Czechia,3889,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,DE,Germany,33601,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,DK,Denmark,5237,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,EE,Estonia,1040,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,EL,Greece,1703,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,ES,Spain,9232,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,FI,Finland,4227,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,HR,Croatia,1290,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,HU,Hungary,2726,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,IE,Ireland,3052,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,IS,Iceland,258,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,IT,Italy,27876,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,LI,Liechtenstein,8,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,LT,Lithuania,1446,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,LU,Luxembourg,461,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,LV,Latvia,448,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,MT,Malta,416,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,NL,Netherlands,7836,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,NO,Norway,3970,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,PL,Poland,2748,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,PT,Portugal,6385,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,RO,Romania,849,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,SE,Sweden,10665,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,SI,Slovenia,1639,
Antimicrobial resistance,"Escherichia coli|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,SK,Slovakia,692,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,AT,Austria,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,BE,Belgium,85.02391757,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,CY,Cyprus,70.9613966,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,CZ,Czechia,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,DE,Germany,99.93018978,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,DK,Denmark,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,EE,Estonia,99.75156621,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,EL,Greece,60.43535761,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,ES,Spain,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,FI,Finland,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,FR,France,-,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,HR,Croatia,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,HU,Hungary,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,IE,Ireland,99.96917385,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,IS,Iceland,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,IT,Italy,99.91534018,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,LI,Liechtenstein,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,LT,Lithuania,99.5954748,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,LV,Latvia,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,MT,Malta,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,NO,Norway,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,PL,Poland,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,PT,Portugal,97.9797616,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,RO,Romania,99.8716193,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,SE,Sweden,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness age,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,AT,Austria,98.74320652,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,BE,Belgium,93.09807082,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,CY,Cyprus,74.60044258,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,CZ,Czechia,99.97596635,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,DE,Germany,88.0947317,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,DK,Denmark,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,EE,Estonia,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,EL,Greece,70.61872252,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,ES,Spain,95.69504132,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,FI,Finland,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,FR,France,-,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,HR,Croatia,99.77222878,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,HU,Hungary,81.66319331,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,IE,Ireland,99.97602411,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,IS,Iceland,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,IT,Italy,99.61525888,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,LI,Liechtenstein,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,LT,Lithuania,0,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,LV,Latvia,99.57660756,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,MT,Malta,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,NO,Norway,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,PL,Poland,99.20468575,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,PT,Portugal,99.97479203,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,RO,Romania,94.7107155,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,SE,Sweden,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Escherichia coli|Data quality,Completeness gender,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,149,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,116,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,9,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,15,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,132,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,1071,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,33,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,35,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,61,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,462,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,108,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,23,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,28,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,37,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,11,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,1999,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,7,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,6,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,15,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,0,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,148,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,40,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,83,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,208,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,35,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,219,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,25,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,35,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,AT,Austria,813,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,BE,Belgium,904,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,BG,Bulgaria,122,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,CY,Cyprus,142,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,CZ,Czechia,668,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,DE,Germany,5895,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,DK,Denmark,610,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,EE,Estonia,140,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,EL,Greece,703,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,ES,Spain,2650,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,FI,Finland,439,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,HR,Croatia,385,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,HU,Hungary,710,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,IE,Ireland,489,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,IS,Iceland,33,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,IT,Italy,9558,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,LT,Lithuania,299,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,LU,Luxembourg,72,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,LV,Latvia,129,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,MT,Malta,116,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,NL,Netherlands,1015,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,NO,Norway,402,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,PL,Poland,979,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,PT,Portugal,1557,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,RO,Romania,249,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,SE,Sweden,1574,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,SI,Slovenia,261,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,R - resistant isolates,N,2023,SK,Slovakia,216,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,AT,Austria,15.03050471,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,18.23683679,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,39.86928104,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,42.90030211,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,17.17665209,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,DE,Germany,16.58927817,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,10.46671242,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,13.28273244,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,EL,Greece,37.77538957,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,ES,Spain,27.55537069,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,FI,Finland,10.30274583,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,29.63818321,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,25.98828696,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,15.96995427,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,12.79069767,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,IT,Italy,34.14425034,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,20.54982817,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,15.61822125,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,28.35164835,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,MT,Malta,27.88461538,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,12.94642857,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,NO,Norway,10.12339461,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,PL,Poland,32.20394736,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,24.33192686,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,RO,Romania,25.40816326,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,14.74611204,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,15.92434411,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,31.16883116,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,AT,Austria,4447,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,BE,Belgium,3937,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,BG,Bulgaria,175,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,CY,Cyprus,174,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,CZ,Czechia,3089,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,DE,Germany,28569,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,DK,Denmark,5185,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,EE,Estonia,879,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,EL,Greece,1097,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,ES,Spain,6505,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,FI,Finland,3714,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,HR,Croatia,891,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,HU,Hungary,1994,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,IE,Ireland,2536,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,IS,Iceland,214,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,IT,Italy,16436,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,LI,Liechtenstein,6,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,LT,Lithuania,1149,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,LU,Luxembourg,383,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,LV,Latvia,311,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,MT,Malta,300,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,NL,Netherlands,6677,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,NO,Norway,3529,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,PL,Poland,1978,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,PT,Portugal,4634,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,RO,Romania,696,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,SE,Sweden,8881,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,SI,Slovenia,1353,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,S - susceptible isolates,N,2023,SK,Slovakia,442,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,AT,Austria,5409,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,BE,Belgium,4957,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,BG,Bulgaria,306,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,CY,Cyprus,331,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,CZ,Czechia,3889,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,DE,Germany,35535,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,DK,Denmark,5828,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,EE,Estonia,1054,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,EL,Greece,1861,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,ES,Spain,9617,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,FI,Finland,4261,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,HR,Croatia,1299,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,HU,Hungary,2732,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,IE,Ireland,3062,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,IS,Iceland,258,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,IT,Italy,27993,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,LI,Liechtenstein,8,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,LT,Lithuania,1455,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,LU,Luxembourg,461,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,LV,Latvia,455,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,MT,Malta,416,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,NL,Netherlands,7840,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,NO,Norway,3971,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,PL,Poland,3040,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,PT,Portugal,6399,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,RO,Romania,980,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,SE,Sweden,10674,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,SI,Slovenia,1639,
Antimicrobial resistance,Escherichia coli|Fluoroquinolones,Total tested isolates,N,2023,SK,Slovakia,693,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,14,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,38,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,3,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,36,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,155,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,39,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,14,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,23,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,50,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,30,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,13,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,3,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,33,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,260,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,22,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,3,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,2,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,8,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,38,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,19,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,17,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,43,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,13,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,51,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,13,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,11,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,AT,Austria,541,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,BE,Belgium,500,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,BG,Bulgaria,114,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,CY,Cyprus,115,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,CZ,Czechia,618,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,DE,Germany,3451,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,DK,Denmark,333,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,EE,Estonia,124,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,EL,Greece,397,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,ES,Spain,1503,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,FI,Finland,302,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,HR,Croatia,262,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,HU,Hungary,588,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,IE,Ireland,325,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,IS,Iceland,31,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,IT,Italy,7618,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,LT,Lithuania,251,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,LU,Luxembourg,54,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,LV,Latvia,117,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,MT,Malta,47,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,NL,Netherlands,625,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,NO,Norway,224,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,PL,Poland,600,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,PT,Portugal,1101,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,RO,Romania,189,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,SE,Sweden,850,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,SI,Slovenia,142,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,R - resistant isolates,N,2023,SK,Slovakia,150,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,AT,Austria,9.85248588,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,10.08878127,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,37.25490196,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,34.74320241,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,15.87872559,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,DE,Germany,9.68864931,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,6.31638846,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,11.43911439,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,EL,Greece,22.82921219,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,ES,Spain,16.21534146,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,FI,Finland,7.08587517,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,20,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,21.3352685,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,10.4233483,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,12.01550387,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,IT,Italy,26.67647161,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,16.95945945,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,11.71366594,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,25.37960954,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,MT,Malta,11.29807692,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,7.97193877,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,NO,Norway,5.62248995,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,PL,Poland,19.56309096,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,17.19506481,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,RO,Romania,19.09090909,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,7.92540792,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,8.6638194,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,21.55172413,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,AT,Austria,4936,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,BE,Belgium,4418,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,BG,Bulgaria,192,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,CY,Cyprus,213,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,CZ,Czechia,3238,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,DE,Germany,32013,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,DK,Denmark,4900,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,EE,Estonia,946,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,EL,Greece,1319,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,ES,Spain,7716,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,FI,Finland,3930,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,HR,Croatia,1035,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,HU,Hungary,2165,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,IE,Ireland,2760,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,IS,Iceland,227,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,IT,Italy,20679,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,LI,Liechtenstein,8,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,LT,Lithuania,1207,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,LU,Luxembourg,404,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,LV,Latvia,342,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,MT,Malta,361,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,NL,Netherlands,7177,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,NO,Norway,3741,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,PL,Poland,2450,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,PT,Portugal,5259,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,RO,Romania,788,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,SE,Sweden,9824,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,SI,Slovenia,1484,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,S - susceptible isolates,N,2023,SK,Slovakia,535,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,AT,Austria,5491,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,BE,Belgium,4956,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,BG,Bulgaria,306,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,CY,Cyprus,331,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,CZ,Czechia,3892,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,DE,Germany,35619,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,DK,Denmark,5272,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,EE,Estonia,1084,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,EL,Greece,1739,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,ES,Spain,9269,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,FI,Finland,4262,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,HR,Croatia,1310,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,HU,Hungary,2756,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,IE,Ireland,3118,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,IS,Iceland,258,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,IT,Italy,28557,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,LI,Liechtenstein,8,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,LT,Lithuania,1480,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,LU,Luxembourg,461,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,LV,Latvia,461,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,MT,Malta,416,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,NL,Netherlands,7840,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,NO,Norway,3984,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,PL,Poland,3067,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,PT,Portugal,6403,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,RO,Romania,990,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,SE,Sweden,10725,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,SI,Slovenia,1639,
Antimicrobial resistance,Escherichia coli|Third-generation cephalosporins,Total tested isolates,N,2023,SK,Slovakia,696,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,49,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,1,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,11,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,4,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,1,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,AT,Austria,48,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,BE,Belgium,91,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,BG,Bulgaria,297,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,CY,Cyprus,73,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,CZ,Czechia,611,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,DE,Germany,290,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,DK,Denmark,37,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,EE,Estonia,23,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,EL,Greece,1383,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,ES,Spain,525,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,FI,Finland,38,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,HR,Croatia,210,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,HU,Hungary,361,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,IE,Ireland,50,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,IS,Iceland,2,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,IT,Italy,4503,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,LT,Lithuania,158,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,LU,Luxembourg,9,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,LV,Latvia,59,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,MT,Malta,16,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,NL,Netherlands,94,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,NO,Norway,33,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,PL,Poland,719,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,PT,Portugal,812,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,RO,Romania,457,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,SE,Sweden,97,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,SI,Slovenia,58,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,R - resistant isolates,N,2023,SK,Slovakia,125,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,AT,Austria,3.97350993,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,11.46095717,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,73.33333333,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,33.95348837,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,36.60874775,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,DE,Germany,3.83953396,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,2.64097073,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,7.66666666,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,EL,Greece,64.74719101,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,ES,Spain,16.79462571,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,FI,Finland,5.23415977,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,37.36654804,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,31.41862489,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,8.75656742,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,4.54545454,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,IT,Italy,32.6730518,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,29.25925925,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,10.58823529,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,25.21367521,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,MT,Malta,10.88435374,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,6.25,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,NO,Norway,4.1931385,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,PL,Poland,49.86130374,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,23.75658279,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,RO,Romania,57.05368289,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,4.48243992,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,17.10914454,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,40.32258064,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,AT,Austria,1111,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,BE,Belgium,703,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,BG,Bulgaria,108,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,CY,Cyprus,142,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,CZ,Czechia,1058,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,DE,Germany,7262,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,DK,Denmark,1364,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,EE,Estonia,277,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,EL,Greece,753,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,ES,Spain,2590,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,FI,Finland,688,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,HR,Croatia,352,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,HU,Hungary,788,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,IE,Ireland,521,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,IS,Iceland,42,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,IT,Italy,9275,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,LT,Lithuania,382,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,LU,Luxembourg,76,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,LV,Latvia,175,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,MT,Malta,131,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,NL,Netherlands,1410,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,NO,Norway,753,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,PL,Poland,723,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,PT,Portugal,2606,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,RO,Romania,344,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,SE,Sweden,2067,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,SI,Slovenia,281,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,S - susceptible isolates,N,2023,SK,Slovakia,185,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,AT,Austria,1208,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,BE,Belgium,794,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,BG,Bulgaria,405,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,CY,Cyprus,215,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,CZ,Czechia,1669,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,DE,Germany,7553,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,DK,Denmark,1401,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,EE,Estonia,300,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,EL,Greece,2136,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,ES,Spain,3126,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,FI,Finland,726,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,HR,Croatia,562,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,HU,Hungary,1149,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,IE,Ireland,571,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,IS,Iceland,44,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,IT,Italy,13782,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,LT,Lithuania,540,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,LU,Luxembourg,85,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,LV,Latvia,234,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,MT,Malta,147,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,NL,Netherlands,1504,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,NO,Norway,787,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,PL,Poland,1442,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,PT,Portugal,3418,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,RO,Romania,801,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,SE,Sweden,2164,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,SI,Slovenia,339,
Antimicrobial resistance,Klebsiella pneumoniae|Aminoglycosides,Total tested isolates,N,2023,SK,Slovakia,310,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,5,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,9,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,3,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,14,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,11,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,4,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,3,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,13,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,47,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,2,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,31,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,11,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,4,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,206,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,8,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,4,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,3,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,2,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,1,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,27,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,50,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,9,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,2,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,0,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,16,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,AT,Austria,24,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,BE,Belgium,23,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,BG,Bulgaria,230,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,CY,Cyprus,74,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,CZ,Czechia,20,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,DE,Germany,85,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,DK,Denmark,5,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,EE,Estonia,6,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,EL,Greece,1518,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,ES,Spain,129,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,FI,Finland,1,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,HR,Croatia,157,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,HU,Hungary,66,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,IE,Ireland,2,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,IT,Italy,3616,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,LT,Lithuania,21,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,LU,Luxembourg,2,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,LV,Latvia,15,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,MT,Malta,5,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,NL,Netherlands,6,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,NO,Norway,4,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,PL,Poland,285,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,PT,Portugal,430,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,RO,Romania,496,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,SE,Sweden,11,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,SI,Slovenia,13,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,R - resistant isolates,N,2023,SK,Slovakia,39,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,AT,Austria,1.7977528,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,2.34933605,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,56.79012345,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,33.63636363,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,1.45772594,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,DE,Germany,1.07391029,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,0.3770739,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,2.28136882,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,EL,Greece,69.66498393,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,ES,Spain,4.29570429,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,FI,Finland,0.13755158,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,27.64084507,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,5.80985915,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,0.35523978,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,0,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,IT,Italy,26.48308188,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,3.88170055,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,2.38095238,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,6.41025641,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,MT,Malta,3.40136054,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,0.4045853,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,NO,Norway,0.50825921,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,PL,Poland,18.12977099,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,13.10975609,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,RO,Romania,52.76595744,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,0.50831792,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,3.83480825,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,12.58064516,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,AT,Austria,1306,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,BE,Belgium,947,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,BG,Bulgaria,175,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,CY,Cyprus,143,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,CZ,Czechia,1338,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,DE,Germany,7819,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,DK,Denmark,1317,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,EE,Estonia,254,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,EL,Greece,648,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,ES,Spain,2827,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,FI,Finland,724,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,HR,Croatia,380,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,HU,Hungary,1059,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,IE,Ireland,557,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,IS,Iceland,44,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,IT,Italy,9832,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,LT,Lithuania,512,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,LU,Luxembourg,82,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,LV,Latvia,215,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,MT,Malta,139,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,NL,Netherlands,1475,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,NO,Norway,782,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,PL,Poland,1260,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,PT,Portugal,2800,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,RO,Romania,435,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,SE,Sweden,2151,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,SI,Slovenia,326,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,S - susceptible isolates,N,2023,SK,Slovakia,255,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,AT,Austria,1335,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,BE,Belgium,979,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,BG,Bulgaria,405,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,CY,Cyprus,220,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,CZ,Czechia,1372,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,DE,Germany,7915,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,DK,Denmark,1326,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,EE,Estonia,263,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,EL,Greece,2179,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,ES,Spain,3003,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,FI,Finland,727,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,HR,Croatia,568,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,HU,Hungary,1136,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,IE,Ireland,563,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,IS,Iceland,44,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,IT,Italy,13654,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,LT,Lithuania,541,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,LU,Luxembourg,84,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,LV,Latvia,234,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,MT,Malta,147,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,NL,Netherlands,1483,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,NO,Norway,787,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,PL,Poland,1572,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,PT,Portugal,3280,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,RO,Romania,940,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,SE,Sweden,2164,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,SI,Slovenia,339,
Antimicrobial resistance,Klebsiella pneumoniae|Carbapenems,Total tested isolates,N,2023,SK,Slovakia,310,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,AT,Austria,31,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,BE,Belgium,72,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,BG,Bulgaria,263,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,CY,Cyprus,65,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,CZ,Czechia,472,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,DE,Germany,211,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,DK,Denmark,21,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,EE,Estonia,16,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,EL,Greece,1287,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,ES,Spain,421,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,FI,Finland,24,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,HR,Croatia,191,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,HU,Hungary,303,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,IE,Ireland,31,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,IT,Italy,3997,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,LT,Lithuania,130,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,LU,Luxembourg,7,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,LV,Latvia,52,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,MT,Malta,12,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,NL,Netherlands,68,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,NO,Norway,21,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,PL,Poland,675,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,PT,Portugal,702,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,RO,Romania,429,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,SE,Sweden,65,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,SI,Slovenia,47,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",R - resistant isolates,N,2023,SK,Slovakia,110,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,AT,Austria,2.78026905,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,BE,Belgium,9.07944514,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,64.9382716,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,CY,Cyprus,30.23255813,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,CZ,Czechia,28.28040742,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,DE,Germany,2.79840848,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,DK,Denmark,1.67865707,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,EE,Estonia,5.4054054,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,EL,Greece,63.1501472,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,ES,Spain,13.9450149,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,FI,Finland,3.30578512,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,HR,Croatia,34.22939068,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,HU,Hungary,26.6022827,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,IE,Ireland,5.53571428,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,IS,Iceland,0,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,IT,Italy,29.83503769,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,LT,Lithuania,24.48210922,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,8.23529411,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,LV,Latvia,22.51082251,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,MT,Malta,8.1632653,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,NL,Netherlands,4.52127659,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,NO,Norway,2.68199233,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,PL,Poland,47.40168539,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,PT,Portugal,20.68355922,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,RO,Romania,54.37262357,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,SE,Sweden,3.01624129,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,SI,Slovenia,13.86430678,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)","R - resistant isolates, percentage  ",%,2023,SK,Slovakia,35.48387096,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,AT,Austria,1115,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,BE,Belgium,793,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,BG,Bulgaria,405,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,CY,Cyprus,215,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,CZ,Czechia,1669,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,DE,Germany,7540,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,DK,Denmark,1251,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,EE,Estonia,296,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,EL,Greece,2038,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,ES,Spain,3019,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,FI,Finland,726,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,HR,Croatia,558,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,HU,Hungary,1139,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,IE,Ireland,560,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,IS,Iceland,44,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,IT,Italy,13397,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,LT,Lithuania,531,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,LU,Luxembourg,85,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,LV,Latvia,231,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,MT,Malta,147,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,NL,Netherlands,1504,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,NO,Norway,783,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,PL,Poland,1424,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,PT,Portugal,3394,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,RO,Romania,789,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,SE,Sweden,2155,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,SI,Slovenia,339,
Antimicrobial resistance,"Klebsiella pneumoniae|Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)",Total tested isolates,N,2023,SK,Slovakia,310,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,AT,Austria,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,BE,Belgium,86.11949305,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,CY,Cyprus,75.57715674,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,CZ,Czechia,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,DE,Germany,99.94196858,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,DK,Denmark,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,EE,Estonia,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,EL,Greece,57.53835012,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,ES,Spain,99.97496174,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,FI,Finland,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,FR,France,-,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,HR,Croatia,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,HU,Hungary,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,IE,Ireland,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,IS,Iceland,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,IT,Italy,99.55779388,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,LI,Liechtenstein,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,LT,Lithuania,99.83004036,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,LV,Latvia,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,MT,Malta,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,NO,Norway,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,PL,Poland,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,PT,Portugal,98.59147819,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,RO,Romania,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,SE,Sweden,99.94972031,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness age,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,AT,Austria,98.07425666,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,BE,Belgium,93.62301347,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,CY,Cyprus,78.93884163,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,CZ,Czechia,98.82195298,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,DE,Germany,88.04684717,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,DK,Denmark,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,EE,Estonia,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,EL,Greece,70.60372638,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,ES,Spain,94.04367784,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,FI,Finland,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,FR,France,-,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,HR,Croatia,99.63330457,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,HU,Hungary,81.2298569,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,IE,Ireland,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,IS,Iceland,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,IT,Italy,99.27878288,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,LI,Liechtenstein,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,LT,Lithuania,0,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,LV,Latvia,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,MT,Malta,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,NO,Norway,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,PL,Poland,99.74971558,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,PT,Portugal,99.97475767,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,RO,Romania,96.73860911,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,SE,Sweden,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Klebsiella pneumoniae|Data quality,Completeness gender,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,42,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,20,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,17,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,18,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,77,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,156,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,11,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,7,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,30,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,124,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,30,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,12,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,11,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,10,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,907,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,35,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,4,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,7,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,0,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,29,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,11,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,40,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,145,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,36,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,55,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,9,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,18,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,AT,Austria,181,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,BE,Belgium,214,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,BG,Bulgaria,297,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,CY,Cyprus,121,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,CZ,Czechia,632,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,DE,Germany,908,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,DK,Denmark,99,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,EE,Estonia,50,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,EL,Greece,1666,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,ES,Spain,812,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,FI,Finland,65,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,HR,Croatia,320,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,HU,Hungary,433,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,IE,Ireland,87,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,IS,Iceland,5,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,IT,Italy,6784,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,LT,Lithuania,224,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,LU,Luxembourg,16,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,LV,Latvia,84,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,MT,Malta,43,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,NL,Netherlands,170,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,NO,Norway,92,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,PL,Poland,998,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,PT,Portugal,1509,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,RO,Romania,598,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,SE,Sweden,273,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,SI,Slovenia,92,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,R - resistant isolates,N,2023,SK,Slovakia,141,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,AT,Austria,13.89102072,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,21.88139059,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,73.33333333,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,55,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,37.86698621,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,DE,Germany,11.49367088,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,7.09169054,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,16.83501683,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,EL,Greece,76.91597414,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,ES,Spain,25.91765081,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,FI,Finland,8.94085281,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,56.53710247,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,38.01580333,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,15.50802139,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,11.36363636,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,IT,Italy,50.07750793,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,42.10526315,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,18.82352941,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,36.20689655,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,MT,Malta,29.25170068,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,11.30319148,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,NO,Norway,11.74968071,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,PL,Poland,63.64795918,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,44.18740849,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,RO,Romania,63.95721925,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,12.66821345,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,27.13864306,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,45.48387096,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,AT,Austria,1080,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,BE,Belgium,744,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,BG,Bulgaria,91,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,CY,Cyprus,81,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,CZ,Czechia,960,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,DE,Germany,6836,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,DK,Denmark,1286,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,EE,Estonia,240,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,EL,Greece,470,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,ES,Spain,2197,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,FI,Finland,632,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,HR,Croatia,234,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,HU,Hungary,695,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,IE,Ireland,464,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,IS,Iceland,39,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,IT,Italy,5856,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,LT,Lithuania,273,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,LU,Luxembourg,65,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,LV,Latvia,141,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,MT,Malta,104,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,NL,Netherlands,1305,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,NO,Norway,680,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,PL,Poland,530,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,PT,Portugal,1761,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,RO,Romania,301,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,SE,Sweden,1827,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,SI,Slovenia,238,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,S - susceptible isolates,N,2023,SK,Slovakia,151,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,AT,Austria,1303,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,BE,Belgium,978,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,BG,Bulgaria,405,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,CY,Cyprus,220,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,CZ,Czechia,1669,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,DE,Germany,7900,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,DK,Denmark,1396,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,EE,Estonia,297,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,EL,Greece,2166,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,ES,Spain,3133,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,FI,Finland,727,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,HR,Croatia,566,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,HU,Hungary,1139,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,IE,Ireland,561,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,IS,Iceland,44,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,IT,Italy,13547,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,LT,Lithuania,532,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,LU,Luxembourg,85,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,LV,Latvia,232,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,MT,Malta,147,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,NL,Netherlands,1504,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,NO,Norway,783,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,PL,Poland,1568,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,PT,Portugal,3415,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,RO,Romania,935,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,SE,Sweden,2155,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,SI,Slovenia,339,
Antimicrobial resistance,Klebsiella pneumoniae|Fluoroquinolones,Total tested isolates,N,2023,SK,Slovakia,310,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,19,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,14,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,5,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,20,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,120,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,20,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,3,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,5,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,31,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,17,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,6,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,1,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,7,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,239,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,15,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,4,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,4,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,7,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,10,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,8,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,10,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,96,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,4,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,22,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,9,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,5,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,AT,Austria,194,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,BE,Belgium,195,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,BG,Bulgaria,330,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,CY,Cyprus,133,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,CZ,Czechia,772,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,DE,Germany,784,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,DK,Denmark,72,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,EE,Estonia,39,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,EL,Greece,1571,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,ES,Spain,766,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,FI,Finland,63,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,HR,Croatia,313,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,HU,Hungary,483,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,IE,Ireland,91,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,IS,Iceland,3,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,IT,Italy,7624,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,LT,Lithuania,235,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,LU,Luxembourg,18,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,LV,Latvia,97,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,MT,Malta,37,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,NL,Netherlands,153,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,NO,Norway,46,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,PL,Poland,1012,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,PT,Portugal,1725,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,RO,Romania,650,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,SE,Sweden,215,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,SI,Slovenia,78,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,R - resistant isolates,N,2023,SK,Slovakia,163,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,AT,Austria,14.01734104,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,19.91828396,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,81.48148148,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,60.45454545,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,46.25524266,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,DE,Germany,9.90649481,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,5.70975416,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,12.95681063,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,EL,Greece,75.60153994,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,ES,Spain,25.25552258,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,FI,Finland,8.66574965,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,55.30035335,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,42.03655352,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,15.96491228,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,6.81818181,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,IT,Italy,55.17441018,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,43.43807763,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,21.17647058,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,41.27659574,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,MT,Malta,25.17006802,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,10.17287234,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,NO,Norway,5.84498094,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,PL,Poland,64.33566433,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,50.69056714,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,RO,Romania,69.44444444,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,9.93071593,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,23.00884955,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,52.58064516,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,AT,Austria,1171,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,BE,Belgium,770,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,BG,Bulgaria,75,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,CY,Cyprus,82,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,CZ,Czechia,877,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,DE,Germany,7010,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,DK,Denmark,1169,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,EE,Estonia,259,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,EL,Greece,502,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,ES,Spain,2236,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,FI,Finland,647,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,HR,Croatia,247,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,HU,Hungary,665,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,IE,Ireland,472,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,IS,Iceland,41,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,IT,Italy,5955,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,LT,Lithuania,291,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,LU,Luxembourg,63,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,LV,Latvia,134,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,MT,Malta,103,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,NL,Netherlands,1341,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,NO,Norway,733,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,PL,Poland,551,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,PT,Portugal,1582,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,RO,Romania,282,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,SE,Sweden,1928,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,SI,Slovenia,252,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,S - susceptible isolates,N,2023,SK,Slovakia,142,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,AT,Austria,1384,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,BE,Belgium,979,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,BG,Bulgaria,405,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,CY,Cyprus,220,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,CZ,Czechia,1669,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,DE,Germany,7914,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,DK,Denmark,1261,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,EE,Estonia,301,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,EL,Greece,2078,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,ES,Spain,3033,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,FI,Finland,727,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,HR,Croatia,566,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,HU,Hungary,1149,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,IE,Ireland,570,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,IS,Iceland,44,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,IT,Italy,13818,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,LT,Lithuania,541,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,LU,Luxembourg,85,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,LV,Latvia,235,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,MT,Malta,147,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,NL,Netherlands,1504,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,NO,Norway,787,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,PL,Poland,1573,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,PT,Portugal,3403,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,RO,Romania,936,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,SE,Sweden,2165,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,SI,Slovenia,339,
Antimicrobial resistance,Klebsiella pneumoniae|Third-generation cephalosporins,Total tested isolates,N,2023,SK,Slovakia,310,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,5,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,3,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,2,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,15,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,AT,Austria,10,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,BE,Belgium,15,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,BG,Bulgaria,16,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,CY,Cyprus,5,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,CZ,Czechia,81,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,DE,Germany,55,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,DK,Denmark,2,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,EE,Estonia,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,EL,Greece,424,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,ES,Spain,89,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,FI,Finland,4,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,HR,Croatia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,HU,Hungary,74,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,IE,Ireland,2,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,IT,Italy,301,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,LT,Lithuania,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,LU,Luxembourg,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,LV,Latvia,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,MT,Malta,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,NL,Netherlands,5,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,NO,Norway,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,PL,Poland,57,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,PT,Portugal,39,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,RO,Romania,87,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,SE,Sweden,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,SI,Slovenia,4,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,R - resistant isolates,N,2023,SK,Slovakia,73,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,AT,Austria,2.25225225,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,7.17703349,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,19.04761904,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,6.25,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,13.25695581,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,DE,Germany,1.6991041,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,0.75471698,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,-,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,EL,Greece,46.08695652,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,ES,Spain,6.77837014,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,FI,Finland,1.08991825,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,-,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,7.88912579,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,0.83333333,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,IT,Italy,6.97081982,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,-,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,2.22222222,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,-,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,MT,Malta,2.5,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,0.64516129,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,NO,Norway,0.34013605,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,PL,Poland,17.70186335,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,3.72492836,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,RO,Romania,44.16243654,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,0.16949152,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,1.73913043,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,33.79629629,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,AT,Austria,429,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,BE,Belgium,194,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,BG,Bulgaria,68,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,CY,Cyprus,75,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,CZ,Czechia,530,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,DE,Germany,3179,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,DK,Denmark,263,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,EE,Estonia,12,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,EL,Greece,496,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,ES,Spain,1222,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,FI,Finland,363,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,HR,Croatia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,HU,Hungary,864,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,IE,Ireland,238,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,IS,Iceland,27,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,IT,Italy,4002,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,LI,Liechtenstein,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,LT,Lithuania,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,LU,Luxembourg,44,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,LV,Latvia,6,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,MT,Malta,39,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,NL,Netherlands,770,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,NO,Norway,293,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,PL,Poland,265,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,PT,Portugal,1007,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,RO,Romania,110,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,SE,Sweden,589,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,SI,Slovenia,226,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,S - susceptible isolates,N,2023,SK,Slovakia,143,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,AT,Austria,444,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,BE,Belgium,209,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,BG,Bulgaria,84,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,CY,Cyprus,80,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,CZ,Czechia,611,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,DE,Germany,3237,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,DK,Denmark,265,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,EE,Estonia,13,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,EL,Greece,920,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,ES,Spain,1313,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,FI,Finland,367,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,HR,Croatia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,HU,Hungary,938,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,IE,Ireland,240,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,IS,Iceland,27,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,IT,Italy,4318,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,LI,Liechtenstein,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,LT,Lithuania,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,LU,Luxembourg,45,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,LV,Latvia,7,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,MT,Malta,40,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,NL,Netherlands,775,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,NO,Norway,294,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,PL,Poland,322,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,PT,Portugal,1047,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,RO,Romania,197,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,SE,Sweden,590,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,SI,Slovenia,230,
Antimicrobial resistance,Pseudomonas aeruginosa|Aminoglycosides,Total tested isolates,N,2023,SK,Slovakia,216,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,497,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,206,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,56,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,77,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,92,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,3016,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,12,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,55,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,506,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,255,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,9,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,260,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,653,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,66,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,4400,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,87,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,40,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,29,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,38,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,714,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,162,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,304,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,795,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,119,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,621,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,205,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,87,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,AT,Austria,101,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,BE,Belgium,54,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,BG,Bulgaria,28,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,CY,Cyprus,26,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,CZ,Czechia,123,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,DE,Germany,428,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,DK,Denmark,15,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,EE,Estonia,10,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,EL,Greece,691,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,ES,Spain,207,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,FI,Finland,25,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,HR,Croatia,105,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,HU,Hungary,294,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,IE,Ireland,19,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,IS,Iceland,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,IT,Italy,1061,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,LT,Lithuania,20,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,LU,Luxembourg,6,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,LV,Latvia,10,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,MT,Malta,2,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,NL,Netherlands,51,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,NO,Norway,21,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,PL,Poland,122,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,PT,Portugal,120,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,RO,Romania,138,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,SE,Sweden,83,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,SI,Slovenia,28,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,R - resistant isolates,N,2023,SK,Slovakia,99,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,AT,Austria,14.20534458,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,11.61290322,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,33.33333333,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,24.76190476,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,20.16393442,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,DE,Germany,12.3592261,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,3.28227571,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,13.69863013,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,EL,Greece,53.40030911,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,ES,Spain,15.09846827,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,FI,Finland,6.8119891,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,28.68852459,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,30.94736842,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,6.62020905,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,3.7037037,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,IT,Italy,15.98854731,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,14.08450704,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,12.76595744,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,22.72727272,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,MT,Malta,5,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,6.59767141,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,NO,Norway,7.14285714,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,PL,Poland,25.6302521,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,10.1608806,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,RO,Romania,52.67175572,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,9.68494749,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,11.96581196,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,43.42105263,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,AT,Austria,113,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,BE,Belgium,205,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,CY,Cyprus,2,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,CZ,Czechia,395,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,DE,Germany,19,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,DK,Denmark,430,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,EE,Estonia,8,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,EL,Greece,97,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,ES,Spain,909,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,FI,Finland,333,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,HR,Croatia,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,HU,Hungary,3,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,IE,Ireland,202,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,IS,Iceland,25,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,IT,Italy,1175,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,LT,Lithuania,35,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,LU,Luxembourg,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,LV,Latvia,5,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,MT,Malta,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,NL,Netherlands,8,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,NO,Norway,111,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,PL,Poland,50,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,PT,Portugal,266,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,RO,Romania,5,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,SE,Sweden,153,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,SI,Slovenia,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,S - susceptible isolates,N,2023,SK,Slovakia,42,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,AT,Austria,711,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,BE,Belgium,465,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,BG,Bulgaria,84,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,CY,Cyprus,105,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,CZ,Czechia,610,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,DE,Germany,3463,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,DK,Denmark,457,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,EE,Estonia,73,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,EL,Greece,1294,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,ES,Spain,1371,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,FI,Finland,367,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,HR,Croatia,366,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,HU,Hungary,950,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,IE,Ireland,287,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,IS,Iceland,27,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,IT,Italy,6636,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,LT,Lithuania,142,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,LU,Luxembourg,47,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,LV,Latvia,44,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,MT,Malta,40,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,NL,Netherlands,773,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,NO,Norway,294,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,PL,Poland,476,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,PT,Portugal,1181,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,RO,Romania,262,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,SE,Sweden,857,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,SI,Slovenia,234,
Antimicrobial resistance,Pseudomonas aeruginosa|Carbapenems,Total tested isolates,N,2023,SK,Slovakia,228,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,631,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,383,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,51,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,75,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,486,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,3124,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,218,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,75,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,558,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,331,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,292,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,778,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,201,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,25,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,4821,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,128,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,18,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,28,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,36,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,751,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,266,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,375,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,936,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,131,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,811,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,206,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,158,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,AT,Austria,79,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,BE,Belgium,41,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,BG,Bulgaria,33,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,CY,Cyprus,19,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,CZ,Czechia,125,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,DE,Germany,329,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,DK,Denmark,13,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,EE,Estonia,3,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,EL,Greece,648,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,ES,Spain,102,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,FI,Finland,13,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,HR,Croatia,71,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,HU,Hungary,169,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,IE,Ireland,19,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,IS,Iceland,2,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,IT,Italy,1159,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,LT,Lithuania,14,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,LU,Luxembourg,8,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,LV,Latvia,13,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,MT,Malta,4,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,NL,Netherlands,22,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,NO,Norway,19,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,PL,Poland,102,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,PT,Portugal,159,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,RO,Romania,124,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,SE,Sweden,46,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,SI,Slovenia,26,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,R - resistant isolates,N,2023,SK,Slovakia,70,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,AT,Austria,11.0181311,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,9.09090909,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,39.28571428,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,18.09523809,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,20.45826513,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,DE,Germany,9.51967592,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,3.03030303,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,3.84615384,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,EL,Greece,52.72579332,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,ES,Spain,7.40203193,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,FI,Finland,3.54223433,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,19.5054945,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,17.84582893,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,6.81003584,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,7.4074074,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,IT,Italy,17.7624521,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,9.85915492,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,17.02127659,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,31.70731707,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,MT,Malta,10,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,2.84605433,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,NO,Norway,6.66666666,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,PL,Poland,21.33891213,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,13.4631668,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,RO,Romania,48.62745098,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,5.36756126,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,11.11111111,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,30.70175438,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,AT,Austria,7,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,BE,Belgium,27,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,CY,Cyprus,11,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,CZ,Czechia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,DE,Germany,3,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,DK,Denmark,198,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,EE,Estonia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,EL,Greece,23,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,ES,Spain,945,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,FI,Finland,354,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,HR,Croatia,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,HU,Hungary,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,IE,Ireland,59,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,IT,Italy,545,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,LT,Lithuania,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,LU,Luxembourg,21,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,LV,Latvia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,MT,Malta,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,NL,Netherlands,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,NO,Norway,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,PL,Poland,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,PT,Portugal,86,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,RO,Romania,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,SE,Sweden,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,SI,Slovenia,2,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,S - susceptible isolates,N,2023,SK,Slovakia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,AT,Austria,717,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,BE,Belgium,451,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,BG,Bulgaria,84,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,CY,Cyprus,105,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,CZ,Czechia,611,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,DE,Germany,3456,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,DK,Denmark,429,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,EE,Estonia,78,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,EL,Greece,1229,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,ES,Spain,1378,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,FI,Finland,367,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,HR,Croatia,364,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,HU,Hungary,947,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,IE,Ireland,279,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,IS,Iceland,27,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,IT,Italy,6525,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,LT,Lithuania,142,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,LU,Luxembourg,47,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,LV,Latvia,41,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,MT,Malta,40,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,NL,Netherlands,773,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,NO,Norway,285,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,PL,Poland,478,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,PT,Portugal,1181,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,RO,Romania,255,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,SE,Sweden,857,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,SI,Slovenia,234,
Antimicrobial resistance,Pseudomonas aeruginosa|Ceftazidime,Total tested isolates,N,2023,SK,Slovakia,228,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,AT,Austria,12,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,BE,Belgium,17,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,BG,Bulgaria,26,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,CY,Cyprus,13,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,CZ,Czechia,93,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,DE,Germany,201,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,DK,Denmark,5,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,EE,Estonia,0,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,EL,Greece,413,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,ES,Spain,94,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,FI,Finland,7,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,HR,Croatia,0,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,HU,Hungary,118,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,IE,Ireland,10,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,IS,Iceland,1,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,IT,Italy,489,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,LT,Lithuania,0,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,LU,Luxembourg,5,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,LV,Latvia,2,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,MT,Malta,2,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,NL,Netherlands,13,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,NO,Norway,4,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,PL,Poland,72,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,PT,Portugal,80,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,RO,Romania,94,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,SE,Sweden,20,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,SI,Slovenia,15,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",R - resistant isolates,N,2023,SK,Slovakia,67,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,AT,Austria,4.18118466,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,BE,Belgium,8.54271356,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,30.95238095,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,CY,Cyprus,16.25,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,CZ,Czechia,15.27093596,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,DE,Germany,6.23836126,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,DK,Denmark,1.90114068,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,EE,Estonia,-,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,EL,Greece,48.53113983,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,ES,Spain,7.83986655,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,FI,Finland,1.93370165,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,HR,Croatia,-,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,HU,Hungary,12.74298056,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,IE,Ireland,4.34782608,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,IS,Iceland,3.7037037,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,IT,Italy,11.95599022,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,LT,Lithuania,-,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,11.11111111,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,LV,Latvia,-,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,MT,Malta,5,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,NL,Netherlands,1.76870748,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,NO,Norway,1.59362549,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,PL,Poland,23.07692307,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,PT,Portugal,7.7369439,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,RO,Romania,49.47368421,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,SE,Sweden,3.3898305,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,SI,Slovenia,6.52173913,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)","R - resistant isolates, percentage  ",%,2023,SK,Slovakia,31.16279069,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,AT,Austria,287,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,BE,Belgium,199,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,BG,Bulgaria,84,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,CY,Cyprus,80,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,CZ,Czechia,609,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,DE,Germany,3222,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,DK,Denmark,263,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,EE,Estonia,13,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,EL,Greece,851,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,ES,Spain,1199,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,FI,Finland,362,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,HR,Croatia,0,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,HU,Hungary,926,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,IE,Ireland,230,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,IS,Iceland,27,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,IT,Italy,4090,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,LI,Liechtenstein,1,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,LT,Lithuania,0,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,LU,Luxembourg,45,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,LV,Latvia,7,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,MT,Malta,40,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,NL,Netherlands,735,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,NO,Norway,251,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,PL,Poland,312,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,PT,Portugal,1034,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,RO,Romania,190,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,SE,Sweden,590,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,SI,Slovenia,230,
Antimicrobial resistance,"Pseudomonas aeruginosa|Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl. and carbapenems)",Total tested isolates,N,2023,SK,Slovakia,215,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,AT,Austria,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,BE,Belgium,91.94386694,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,CY,Cyprus,86.053719,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,CZ,Czechia,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,DE,Germany,99.89388513,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,DK,Denmark,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,EE,Estonia,98.29545454,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,EL,Greece,57.74010369,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,ES,Spain,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,FI,Finland,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,FR,France,-,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,HR,Croatia,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,HU,Hungary,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,IE,Ireland,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,IS,Iceland,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,IT,Italy,99.39250236,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,LI,Liechtenstein,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,LT,Lithuania,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,LV,Latvia,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,MT,Malta,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,NO,Norway,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,PL,Poland,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,PT,Portugal,98.26116604,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,RO,Romania,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,SE,Sweden,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness age,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,AT,Austria,98.48700605,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,BE,Belgium,97.29729729,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,CY,Cyprus,85.95041322,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,CZ,Czechia,98.93846153,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,DE,Germany,88.38705398,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,DK,Denmark,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,EE,Estonia,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,EL,Greece,71.36038186,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,ES,Spain,94.67162329,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,FI,Finland,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,FR,France,-,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,HR,Croatia,99.73226238,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,HU,Hungary,80.97884163,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,IE,Ireland,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,IS,Iceland,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,IT,Italy,99.18793683,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,LI,Liechtenstein,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,LT,Lithuania,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,LV,Latvia,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,MT,Malta,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,NO,Norway,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,PL,Poland,99.75866608,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,PT,Portugal,99.93181043,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,RO,Romania,97.82608695,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,SE,Sweden,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Data quality,Completeness gender,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,590,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,365,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,58,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,16,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,472,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,3145,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,212,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,67,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,519,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,276,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,69,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,252,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,799,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,182,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,25,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,4938,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,126,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,40,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,29,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,37,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,706,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,269,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,297,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,920,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,132,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,777,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,212,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,135,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,AT,Austria,56,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,BE,Belgium,73,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,BG,Bulgaria,26,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,CY,Cyprus,19,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,CZ,Czechia,139,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,DE,Germany,309,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,DK,Denmark,27,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,EE,Estonia,10,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,EL,Greece,670,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,ES,Spain,271,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,FI,Finland,27,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,HR,Croatia,114,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,HU,Hungary,149,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,IE,Ireland,21,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,IS,Iceland,2,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,IT,Italy,1067,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,LT,Lithuania,14,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,LU,Luxembourg,4,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,LV,Latvia,11,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,MT,Malta,3,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,NL,Netherlands,69,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,NO,Norway,24,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,PL,Poland,119,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,PT,Portugal,177,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,RO,Romania,128,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,SE,Sweden,79,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,SI,Slovenia,22,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,R - resistant isolates,N,2023,SK,Slovakia,93,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,AT,Austria,8.57580398,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,15.66523605,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,30.95238095,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,18.09523809,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,22.74959083,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,DE,Germany,8.92805547,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,5.85683297,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,12.98701298,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,EL,Greece,51.97827773,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,ES,Spain,18.95104895,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,FI,Finland,7.39726027,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,31.14754098,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,15.71729957,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,7.58122743,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,7.4074074,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,IT,Italy,16.02102102,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,10,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,8.51063829,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,25,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,MT,Malta,7.5,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,8.9032258,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,NO,Norway,8.19112627,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,PL,Poland,24.94758909,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,14.92411467,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,RO,Romania,49.23076923,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,9.21820303,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,9.4017094,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,40.78947368,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,AT,Austria,7,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,BE,Belgium,28,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,CY,Cyprus,70,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,CZ,Czechia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,DE,Germany,7,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,DK,Denmark,222,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,EE,Estonia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,EL,Greece,100,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,ES,Spain,883,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,FI,Finland,269,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,HR,Croatia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,HU,Hungary,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,IE,Ireland,74,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,IT,Italy,655,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,LT,Lithuania,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,LU,Luxembourg,3,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,LV,Latvia,4,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,MT,Malta,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,NL,Netherlands,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,NO,Norway,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,PL,Poland,61,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,PT,Portugal,89,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,RO,Romania,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,SE,Sweden,1,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,SI,Slovenia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,S - susceptible isolates,N,2023,SK,Slovakia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,AT,Austria,653,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,BE,Belgium,466,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,BG,Bulgaria,84,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,CY,Cyprus,105,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,CZ,Czechia,611,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,DE,Germany,3461,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,DK,Denmark,461,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,EE,Estonia,77,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,EL,Greece,1289,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,ES,Spain,1430,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,FI,Finland,365,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,HR,Croatia,366,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,HU,Hungary,948,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,IE,Ireland,277,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,IS,Iceland,27,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,IT,Italy,6660,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,LT,Lithuania,140,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,LU,Luxembourg,47,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,LV,Latvia,44,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,MT,Malta,40,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,NL,Netherlands,775,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,NO,Norway,293,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,PL,Poland,477,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,PT,Portugal,1186,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,RO,Romania,260,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,SE,Sweden,857,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,SI,Slovenia,234,
Antimicrobial resistance,Pseudomonas aeruginosa|Fluoroquinolones,Total tested isolates,N,2023,SK,Slovakia,228,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,530,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,380,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,52,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,46,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,467,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,2997,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,215,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,75,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,410,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,189,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,325,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,767,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,181,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,26,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,4493,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,124,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,18,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,34,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,35,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,693,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,239,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,268,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,913,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,124,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,791,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,205,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,163,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,AT,Austria,67,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,BE,Belgium,57,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,BG,Bulgaria,32,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,CY,Cyprus,30,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,CZ,Czechia,143,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,DE,Germany,450,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,DK,Denmark,21,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,EE,Estonia,4,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,EL,Greece,659,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,ES,Spain,131,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,FI,Finland,16,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,HR,Croatia,37,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,HU,Hungary,175,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,IE,Ireland,31,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,IS,Iceland,1,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,IT,Italy,1433,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,LT,Lithuania,18,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,LU,Luxembourg,9,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,LV,Latvia,9,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,MT,Malta,5,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,NL,Netherlands,45,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,NO,Norway,22,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,PL,Poland,126,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,PT,Portugal,181,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,RO,Romania,124,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,SE,Sweden,65,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,SI,Slovenia,25,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,R - resistant isolates,N,2023,SK,Slovakia,63,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,AT,Austria,11.20401337,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,12.33766233,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,38.09523809,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,28.57142857,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,23.44262295,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,DE,Germany,13.03214596,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,4.55531453,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,5.06329113,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,EL,Greece,54.37293729,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,ES,Spain,10.05372217,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,FI,Finland,4.39560439,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,10.16483516,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,18.57749469,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,11.15107913,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,3.7037037,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,IT,Italy,22.05633369,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,12.67605633,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,19.14893617,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,20.45454545,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,MT,Malta,12.5,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,6.09756097,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,NO,Norway,8.42911877,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,PL,Poland,26.98072805,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,15.443686,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,RO,Romania,50,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,7.58459743,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,10.68376068,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,27.87610619,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,AT,Austria,1,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,BE,Belgium,25,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,CY,Cyprus,29,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,CZ,Czechia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,DE,Germany,6,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,DK,Denmark,225,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,EE,Estonia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,EL,Greece,143,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,ES,Spain,983,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,FI,Finland,348,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,HR,Croatia,2,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,HU,Hungary,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,IE,Ireland,66,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,IT,Italy,571,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,LT,Lithuania,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,LU,Luxembourg,20,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,LV,Latvia,1,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,MT,Malta,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,NL,Netherlands,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,NO,Norway,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,PL,Poland,73,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,PT,Portugal,78,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,RO,Romania,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,SE,Sweden,1,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,SI,Slovenia,4,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,S - susceptible isolates,N,2023,SK,Slovakia,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,AT,Austria,598,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,BE,Belgium,462,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,BG,Bulgaria,84,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,CY,Cyprus,105,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,CZ,Czechia,610,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,DE,Germany,3453,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,DK,Denmark,461,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,EE,Estonia,79,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,EL,Greece,1212,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,ES,Spain,1303,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,FI,Finland,364,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,HR,Croatia,364,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,HU,Hungary,942,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,IE,Ireland,278,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,IS,Iceland,27,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,IT,Italy,6497,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,LT,Lithuania,142,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,LU,Luxembourg,47,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,LV,Latvia,44,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,MT,Malta,40,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,NL,Netherlands,738,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,NO,Norway,261,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,PL,Poland,467,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,PT,Portugal,1172,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,RO,Romania,248,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,SE,Sweden,857,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,SI,Slovenia,234,
Antimicrobial resistance,Pseudomonas aeruginosa|PiperacillinTazobactam,Total tested isolates,N,2023,SK,Slovakia,226,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,AT,Austria,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,BE,Belgium,86.71521571,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,CY,Cyprus,78.89990982,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,CZ,Czechia,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,DE,Germany,99.90748894,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,DK,Denmark,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,EE,Estonia,99.74683544,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,EL,Greece,58.36521295,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,ES,Spain,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,FI,Finland,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,FR,France,-,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,HR,Croatia,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,HU,Hungary,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,IE,Ireland,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,IS,Iceland,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,IT,Italy,99.30560991,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,LI,Liechtenstein,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,LT,Lithuania,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,LV,Latvia,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,MT,Malta,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,NO,Norway,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,PL,Poland,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,PT,Portugal,98.15832746,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,RO,Romania,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,SE,Sweden,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness age,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,AT,Austria,97.90551815,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,BE,Belgium,93.28037073,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,CY,Cyprus,84.76104598,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,CZ,Czechia,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,DE,Germany,88.27867175,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,DK,Denmark,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,EE,Estonia,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,EL,Greece,70.88752869,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,ES,Spain,94.04271744,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,FI,Finland,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,FR,France,-,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,HR,Croatia,99.59926017,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,HU,Hungary,76.57845384,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,IE,Ireland,99.91576819,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,IS,Iceland,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,IT,Italy,99.06072838,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,LI,Liechtenstein,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,LT,Lithuania,0,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,LV,Latvia,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,MT,Malta,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,NO,Norway,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,PL,Poland,99.50036337,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,PT,Portugal,99.97181113,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,RO,Romania,97.04294766,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,SE,Sweden,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Staphylococcus aureus|Data quality,Completeness gender,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,AT,Austria,148,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,BE,Belgium,102,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,BG,Bulgaria,46,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,CY,Cyprus,117,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,CZ,Czechia,221,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,DE,Germany,822,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,DK,Denmark,28,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,EE,Estonia,9,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,EL,Greece,461,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,ES,Spain,578,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,FI,Finland,60,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,FR,France,0,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,HR,Croatia,220,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,HU,Hungary,419,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,IE,Ireland,120,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,IS,Iceland,8,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,IT,Italy,3962,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,LT,Lithuania,70,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,LU,Luxembourg,11,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,LV,Latvia,25,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,MT,Malta,16,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,NL,Netherlands,66,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,NO,Norway,33,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,PL,Poland,272,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,PT,Portugal,758,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,RO,Romania,297,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,SE,Sweden,168,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,SI,Slovenia,68,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),R - resistant isolates,N,2023,SK,Slovakia,60,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,AT,Austria,4.48892932,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,BE,Belgium,6,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,15.86206896,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,51.09170305,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,9.59201388,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,DE,Germany,4.42911794,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,DK,Denmark,1.4973262,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,EE,Estonia,2.06422018,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,EL,Greece,41.23434704,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,ES,Spain,25.88446036,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,FI,Finland,2.85306704,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,FR,France,-,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,HR,Croatia,30.01364256,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,HU,Hungary,20.6607495,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,IE,Ireland,9.66183574,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,IS,Iceland,6.20155038,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,IT,Italy,26.57455228,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,8.6100861,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,5.78947368,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,LV,Latvia,5.38793103,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,MT,Malta,14.54545454,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,1.76517785,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,NO,Norway,1.92532088,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,PL,Poland,13.92729134,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,PT,Portugal,23.08160779,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,RO,Romania,39.38992042,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,SE,Sweden,2.12255211,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,10.10401188,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,14.42307692,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,AT,Austria,3297,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,BE,Belgium,1700,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,BG,Bulgaria,290,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,CY,Cyprus,229,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,CZ,Czechia,2304,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,DE,Germany,18559,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,DK,Denmark,1870,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,EE,Estonia,436,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,EL,Greece,1118,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,ES,Spain,2233,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,FI,Finland,2103,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,FR,France,0,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,HR,Croatia,733,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,HU,Hungary,2028,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,IE,Ireland,1242,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,IS,Iceland,129,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,IT,Italy,14909,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,LI,Liechtenstein,2,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,LT,Lithuania,813,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,LU,Luxembourg,190,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,LV,Latvia,464,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,MT,Malta,110,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,NL,Netherlands,3739,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,NO,Norway,1714,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,PL,Poland,1953,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,PT,Portugal,3284,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,RO,Romania,754,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,SE,Sweden,7915,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,SI,Slovenia,673,
Antimicrobial resistance,Staphylococcus aureus|Meticillin (MRSA),Total tested isolates,N,2023,SK,Slovakia,416,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,AT,Austria,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,BE,Belgium,99.94158878,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,CY,Cyprus,66.08187134,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,CZ,Czechia,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,DE,Germany,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,DK,Denmark,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,EE,Estonia,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,EL,Greece,57.81990521,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,ES,Spain,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,FI,Finland,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,FR,France,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,HR,Croatia,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,HU,Hungary,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,IE,Ireland,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,IS,Iceland,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,IT,Italy,99.0508832,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,LI,Liechtenstein,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,LT,Lithuania,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,LV,Latvia,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,MT,Malta,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,NO,Norway,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,PL,Poland,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,PT,Portugal,97.54358161,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,RO,Romania,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,SE,Sweden,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness age,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,AT,Austria,99.47177286,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,BE,Belgium,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,BG,Bulgaria,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,CY,Cyprus,75.43859649,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,CZ,Czechia,99.35599284,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,DE,Germany,88.46231155,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,DK,Denmark,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,EE,Estonia,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,EL,Greece,64.69194312,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,ES,Spain,97.57236227,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,FI,Finland,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,FR,France,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,HR,Croatia,99.2211838,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,HU,Hungary,81.6925734,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,IE,Ireland,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,IS,Iceland,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,IT,Italy,99.12997627,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,LI,Liechtenstein,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,LT,Lithuania,0,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,LU,Luxembourg,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,LV,Latvia,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,MT,Malta,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,NL,Netherlands,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,NO,Norway,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,PL,Poland,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,PT,Portugal,99.56418383,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,RO,Romania,91.84149184,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,SE,Sweden,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,SI,Slovenia,100,
Antimicrobial resistance,Streptococcus pneumoniae|Data quality,Completeness gender,%,2023,SK,Slovakia,100,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,1,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,3,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,1,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,11,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,5,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,1,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,2,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,1,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,2,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,AT,Austria,67,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,BE,Belgium,254,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,BG,Bulgaria,11,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,CY,Cyprus,8,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,CZ,Czechia,49,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,DE,Germany,220,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,DK,Denmark,22,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,EE,Estonia,25,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,EL,Greece,19,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,ES,Spain,227,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,FI,Finland,56,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,FR,France,282,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,HR,Croatia,22,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,HU,Hungary,40,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,IE,Ireland,50,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,IS,Iceland,5,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,IT,Italy,449,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,LT,Lithuania,32,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,LU,Luxembourg,7,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,LV,Latvia,4,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,MT,Malta,14,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,NL,Netherlands,73,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,NO,Norway,33,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,PL,Poland,98,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,PT,Portugal,139,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,RO,Romania,24,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,SE,Sweden,71,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,SI,Slovenia,14,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,R - resistant isolates,N,2023,SK,Slovakia,5,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,AT,Austria,10.63492063,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,BE,Belgium,14.83644859,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,BG,Bulgaria,35.48387096,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,CY,Cyprus,25.80645161,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,CZ,Czechia,10.22964509,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,DE,Germany,6.51080201,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,DK,Denmark,3.97830018,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,EE,Estonia,13.44086021,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,EL,Greece,26.02739726,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,ES,Spain,21.1359404,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,FI,Finland,11.22244488,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,FR,France,23.87806943,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,HR,Croatia,16.92307692,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,HU,Hungary,14.33691756,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,IE,Ireland,15.01501501,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,IS,Iceland,13.15789473,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,IT,Italy,26.22663551,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,LT,Lithuania,18.18181818,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,LU,Luxembourg,11.11111111,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,LV,Latvia,5.97014925,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,MT,Malta,53.84615384,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,NL,Netherlands,4.62610899,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,NO,Norway,6.77618069,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,PL,Poland,25,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,PT,Portugal,14.97844827,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,RO,Romania,30,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,SE,Sweden,5.37471612,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,SI,Slovenia,6.03448275,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,"R - resistant isolates, percentage  ",%,2023,SK,Slovakia,17.85714285,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,AT,Austria,562,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,BE,Belgium,1455,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,BG,Bulgaria,20,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,CY,Cyprus,23,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,CZ,Czechia,430,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,DE,Germany,3159,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,DK,Denmark,531,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,EE,Estonia,160,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,EL,Greece,54,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,ES,Spain,836,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,FI,Finland,443,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,FR,France,899,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,HR,Croatia,108,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,HU,Hungary,239,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,IE,Ireland,283,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,IS,Iceland,33,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,IT,Italy,1258,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,LI,Liechtenstein,1,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,LT,Lithuania,144,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,LU,Luxembourg,56,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,LV,Latvia,63,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,MT,Malta,12,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,NL,Netherlands,1504,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,NO,Norway,454,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,PL,Poland,292,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,PT,Portugal,788,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,RO,Romania,56,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,SE,Sweden,1248,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,SI,Slovenia,218,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,S - susceptible isolates,N,2023,SK,Slovakia,23,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,AT,Austria,630,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,BE,Belgium,1712,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,BG,Bulgaria,31,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,CY,Cyprus,31,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,CZ,Czechia,479,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,DE,Germany,3379,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,DK,Denmark,553,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,EE,Estonia,186,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,EL,Greece,73,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,ES,Spain,1074,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,FI,Finland,499,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,FR,France,1181,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,HR,Croatia,130,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,HU,Hungary,279,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,IE,Ireland,333,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,IS,Iceland,38,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,IT,Italy,1712,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,LI,Liechtenstein,1,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,LT,Lithuania,176,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,LU,Luxembourg,63,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,LV,Latvia,67,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,MT,Malta,26,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,NL,Netherlands,1578,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,NO,Norway,487,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,PL,Poland,392,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,PT,Portugal,928,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,RO,Romania,80,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,SE,Sweden,1321,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,SI,Slovenia,232,
Antimicrobial resistance,Streptococcus pneumoniae|Macrolides,Total tested isolates,N,2023,SK,Slovakia,28,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,AT,Austria,27,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,BE,Belgium,178,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,BG,Bulgaria,0,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,CY,Cyprus,0,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,CZ,Czechia,19,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,DE,Germany,134,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,DK,Denmark,19,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,EE,Estonia,5,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,EL,Greece,25,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,ES,Spain,3,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,FI,Finland,32,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,FR,France,337,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,HR,Croatia,16,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,HU,Hungary,16,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,IE,Ireland,53,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,IS,Iceland,5,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,IT,Italy,106,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LT,Lithuania,17,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LU,Luxembourg,5,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,LV,Latvia,7,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,MT,Malta,4,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,NL,Netherlands,60,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,NO,Norway,34,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,PL,Poland,1,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,PT,Portugal,55,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,RO,Romania,18,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,SE,Sweden,83,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,SI,Slovenia,27,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"I - 'susceptible, increased exposure' isolates ",N,2023,SK,Slovakia,3,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,AT,Austria,6.4724919,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,BE,Belgium,13.14252336,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,BG,Bulgaria,22.58064516,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,CY,Cyprus,22.58064516,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,CZ,Czechia,4.17536534,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,DE,Germany,6.19033844,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,DK,Denmark,3.69127516,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,EE,Estonia,4.72440944,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,EL,Greece,39.0625,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,ES,Spain,18.6906019,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,FI,Finland,8.11455847,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,FR,France,30.65198983,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,HR,Croatia,12.59842519,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,HU,Hungary,7.04225352,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,IE,Ireland,16.71554252,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,IS,Iceland,13.15789473,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,IT,Italy,12.91364003,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,LI,Liechtenstein,-,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,LT,Lithuania,9.55056179,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,LU,Luxembourg,12.69841269,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,LV,Latvia,11.76470588,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,MT,Malta,26.92307692,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,NL,Netherlands,7.78546712,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,NO,Norway,7.12830957,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,PL,Poland,9.92063492,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,PT,Portugal,11.24694376,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,RO,Romania,32.46753246,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,SE,Sweden,6.87830687,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,SI,Slovenia,11.63793103,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,"Penicillin non-wild-type isolates, percentage",%,2023,SK,Slovakia,9.375,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,AT,Austria,13,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,BE,Belgium,47,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,BG,Bulgaria,7,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,CY,Cyprus,7,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,CZ,Czechia,1,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,DE,Germany,80,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,DK,Denmark,3,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,EE,Estonia,1,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,EL,Greece,0,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,ES,Spain,174,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,FI,Finland,2,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,FR,France,25,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,HR,Croatia,0,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,HU,Hungary,4,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,IE,Ireland,4,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,IS,Iceland,0,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,IT,Italy,54,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,LI,Liechtenstein,0,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,LT,Lithuania,0,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,LU,Luxembourg,3,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,LV,Latvia,1,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,MT,Malta,3,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,NL,Netherlands,30,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,NO,Norway,1,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,PL,Poland,49,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,PT,Portugal,37,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,RO,Romania,7,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,SE,Sweden,8,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,SI,Slovenia,0,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,R - resistant isolates,N,2023,SK,Slovakia,0,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,AT,Austria,578,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,BE,Belgium,1487,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,BG,Bulgaria,24,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,CY,Cyprus,24,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,CZ,Czechia,459,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,DE,Germany,3243,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,DK,Denmark,574,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,EE,Estonia,121,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,EL,Greece,39,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,ES,Spain,770,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,FI,Finland,385,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,FR,France,819,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,HR,Croatia,111,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,HU,Hungary,264,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,IE,Ireland,284,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,IS,Iceland,33,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,IT,Italy,1079,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,LI,Liechtenstein,1,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,LT,Lithuania,161,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,LU,Luxembourg,55,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,LV,Latvia,60,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,MT,Malta,19,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,NL,Netherlands,1066,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,NO,Norway,456,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,PL,Poland,454,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,PT,Portugal,726,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,RO,Romania,52,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,SE,Sweden,1232,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,SI,Slovenia,205,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,S - susceptible isolates,N,2023,SK,Slovakia,29,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,AT,Austria,618,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,BE,Belgium,1712,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,BG,Bulgaria,31,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,CY,Cyprus,31,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,CZ,Czechia,479,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,DE,Germany,3457,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,DK,Denmark,596,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,EE,Estonia,127,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,EL,Greece,64,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,ES,Spain,947,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,FI,Finland,419,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,FR,France,1181,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,HR,Croatia,127,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,HU,Hungary,284,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,IE,Ireland,341,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,IS,Iceland,38,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,IT,Italy,1239,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,LI,Liechtenstein,1,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,LT,Lithuania,178,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,LU,Luxembourg,63,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,LV,Latvia,68,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,MT,Malta,26,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,NL,Netherlands,1156,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,NO,Norway,491,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,PL,Poland,504,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,PT,Portugal,818,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,RO,Romania,77,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,SE,Sweden,1323,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,SI,Slovenia,232,
Antimicrobial resistance,Streptococcus pneumoniae|Penicillins,Total tested isolates,N,2023,SK,Slovakia,32,